Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
DNA replication	25/207	8.182706699025708E-11	1.2355887115528817E-7	0	0	4.8309178743961345	112.20489388768694	PSMD12;PSMD11;PSMD14;MCM7;PRIM1;CDC20;PSMD6;PSMB4;RNASEH1;ORC1;PSMB3;POLD1;KNTC1;RFC5;RFC3;RFC4;CDC6;POLA2;CENPH;CENPK;MCM5;MCM6;SSBP1;ITGB3BP;NUP37
S phase	17/112	2.6751214641338674E-9	2.01971670542107E-6	0	0	6.07142857142857	119.84557423503567	RFC5;PSMD12;RFC3;PSMD11;RFC4;PSMD14;MCM7;PRIM1;CDC6;PSMD6;POLA2;PSMB4;ORC1;PSMB3;POLD1;MCM5;MCM6
Licensing factor removal from origins	12/61	2.992370768977804E-8	1.5061599537188279E-5	0	0	7.868852459016393	136.32483754547957	CDC20;PSMD6;PSMD12;PSMB4;PSMD11;MCM7;PSMD14;ORC1;PSMB3;MCM5;MCM6;CDC6
Cell cycle checkpoints	16/117	3.6204790923393965E-8	1.3667308573581222E-5	0	0	5.47008547008547	93.72485131444256	RFC5;PSMD12;RFC3;PSMD11;RFC4;PSMD14;MCM7;CDC6;CDC20;PSMD6;PSMB4;ORC1;PSMB3;MCM5;MCM6;ANAPC1
DNA strand elongation	9/31	4.3861349181713674E-8	1.3246127452877528E-5	0	0	11.612903225806452	196.74850451612284	RFC5;RFC3;POLA2;RFC4;MCM7;PRIM1;POLD1;MCM5;MCM6
DNA replication pre-Initiation	13/88	2.771993276351459E-7	6.976183078817839E-5	0	0	5.909090909090909	89.21858042613597	PSMD12;PSMD11;MCM7;PSMD14;PRIM1;CDC6;PSMD6;PSMB4;POLA2;ORC1;PSMB3;MCM5;MCM6
Extension of telomeres	8/28	2.8870930761576555E-7	6.227872207140086E-5	0	0	11.428571428571427	172.08966298339905	RFC5;RFC3;POLA2;RFC4;TERT;DKC1;PRIM1;POLD1
Leading strand biosynthesis	6/14	5.999838486628661E-7	1.1324695143511597E-4	0	0	17.142857142857142	245.59479601693383	RFC5;RFC3;POLA2;RFC4;PRIM1;POLD1
CDK regulation of DNA replication	6/18	3.4058763759439143E-6	5.714303697417012E-4	0	0	13.333333333333332	167.86677696463045	KITLG;MCM7;ORC1;MCM5;CDC6;MCM6
Cell cycle	29/453	4.089815056627425E-6	6.175620735507411E-4	0	0	2.560706401766004	31.770712001187906	PSMD12;PSMD11;MCM7;PSMD14;PRKDC;PRIM1;CDC20;PSMD6;PSMB4;TERT;ORC1;PSMB3;POLD1;KNTC1;RFC5;RFC3;RFC4;TUBB;CDC6;POLA2;KITLG;CENPH;DKC1;CENPK;MCM5;MCM6;ANAPC1;ITGB3BP;NUP37
Activation of the pre-replicative complex	7/30	7.232790508281545E-6	9.928648788641028E-4	0	0	9.333333333333332	110.47759924917348	POLA2;MCM7;ORC1;PRIM1;MCM5;CDC6;MCM6
G2/M checkpoints	8/43	9.688818938967444E-6	0.0012191763831534033	0	0	7.441860465116279	85.91284110893845	RFC5;RFC3;RFC4;MCM7;ORC1;MCM5;CDC6;MCM6
Mitotic G1-G1/S phases	13/135	3.479472428382938E-5	0.004041541051429413	0	0	3.8518518518518516	39.543283611349864	PSMD12;PSMD11;PSMD14;MCM7;PRIM1;CDC6;PSMD6;POLA2;PSMB4;ORC1;PSMB3;MCM5;MCM6
Cooperation of prefoldin and TriC/CCT  in actin and tubulin folding	6/27	4.485191110636981E-5	0.0048375989836156015	0	0	8.888888888888888	88.996838749333	TUBA1C;TUBA1B;VBP1;CCT7;PFDN4;CCT4
Chromosome maintenance	11/103	5.364483479982144E-5	0.005400246703182025	0	0	4.271844660194175	42.00558410223906	RFC5;POLA2;RFC3;RFC4;TERT;CENPH;DKC1;PRIM1;POLD1;CENPK;ITGB3BP
HIF-1 degradation in normoxia	10/88	6.869942295380539E-5	0.006483508041265383	0	0	4.545454545454545	43.57168071945078	MAPK11;PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3;ID1;PSMG3;HDAC9
Ran role in mitotic spindle regulation	4/10	7.190252912035329E-5	0.006386636410101969	0	0	16.0	152.64318589327112	RANBP1;TPX2;RCC1;RAN
HIV factor interactions with host	12/128	8.97544027376109E-5	0.0075293971185440255	0	0	3.75	34.94412553585052	RANBP1;PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;NUP155;PSMB3;RCC1;NUP88;RAN;NUP37
Autodegradation of Cdh1 by Cdh1-APC/C	8/58	9.224722597183384E-5	0.007331226906182584	0	0	5.517241379310344	51.260901220754754	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3;CDC6;ANAPC1
Telomere maintenance	8/59	1.0441362629208512E-4	0.007883228785052427	0	0	5.423728813559322	49.72013760538904	RFC5;RFC3;POLA2;RFC4;TERT;DKC1;PRIM1;POLD1
Cell adhesion molecules (CAMs)	12/133	1.2969183129698465E-4	0.00932546025040223	0	0	3.6090225563909772	32.30201305315237	HLA-DMB;CDH2;ITGA4;NRXN3;HLA-DRA;ITGB8;ITGA6;PVR;HLA-DOB;CD22;HLA-DRB1;PTPRF
Adaptive immune system	31/606	1.4489297559396126E-4	0.009944926961221887	0	0	2.046204620462046	18.087456819153726	PSMD12;PSMD11;PSMD14;CUL3;ITPR1;ITPR3;IFI30;PVR;CDC20;PSMD6;PSMB4;HLA-DMB;PSMB3;GRAP2;SEC61G;HLA-DOB;CTSC;RAP1GAP2;CD74;CXADR;ITGA4;UBE2S;AKT1S1;HLA-DRA;TRIM36;ULBP2;SAE1;HLA-DRB1;ANAPC1;ULBP3;UBE2M
Cycling of Ran in nucleocytoplasmic transport	3/5	1.495978143206718E-4	0.009821421722791933	0	0	23.999999999999996	211.3814424644775	RANBP1;RCC1;RAN
HIV infection	15/200	1.6069795575379561E-4	0.010110579716176307	0	0	2.9999999999999996	26.20795201855987	RANBP1;XRCC6;PSMD12;PSMD11;PSMD14;NUP155;GTF2H3;PSMD6;PSMB4;PSMB3;RCC1;TCEA1;NUP88;RAN;NUP37
Interleukin-2 signaling pathway	39/847	1.9246204767502722E-4	0.011624707679571643	0	0	1.841794569067296	15.757678940531237	APP;CXCL8;TXK;NRXN3;SLC1A5;PREX1;ABLIM1;TERT;BAG2;CHSY1;TLK1;PMAIP1;KCNN4;CTSC;CD55;RFC5;YARS;TRAP1;ACTN1;LIF;RAB27B;CTPS1;PA2G4;NMI;EIF2S2;NME1;ADAM19;MAPK11;TPST1;BOP1;P2RX5;MMP16;MTHFD2;DKC1;TMX1;CAMK4;NOS1AP;ID3;SSBP1
Mismatch repair	5/23	2.2182233804738793E-4	0.012882758863521375	0	0	8.695652173913043	73.16203283088741	RFC5;RFC3;RFC4;POLD1;SSBP1
Proteasome complex	5/24	2.7447716067582136E-4	0.015350389356314454	0	0	8.333333333333334	68.33868753202543	PSMD12;PSMB4;PSMD11;PSMD14;PSMB3
Gap junction pathway	9/90	4.1684181088090814E-4	0.022479683372506117	0	0	4.0	31.131215034170143	TUBA1C;TUBA1B;PLCB4;EGF;TUBB;ITPR1;ADRB1;ITPR3;PLCB1
Leishmaniasis	8/72	4.246258481404937E-4	0.022109828644556743	0	0	4.444444444444444	34.5080094848819	MAPK11;HLA-DMB;ITGA4;IRAK1;HLA-DRA;IL12A;HLA-DOB;HLA-DRB1
Degradation of beta-catenin by the destruction complex	8/73	4.666366038644081E-4	0.023487375727841875	0	0	4.383561643835616	33.62174138474373	CDC20;PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3;CSNK1A1
Rev-mediated nuclear export of HIV-1 RNA	5/27	4.900884221165821E-4	0.02387204894825932	0	0	7.4074074074074066	56.45129429511253	RANBP1;NUP155;RCC1;NUP88;RAN
Gap-filling DNA repair biosynthesis and ligation in global genomic nucleotide excision repair	4/16	5.530201160022324E-4	0.026095636723855342	0	0	10.0	75.00116180969299	RFC5;RFC3;RFC4;POLD1
Type 1 diabetes mellitus	6/43	6.586975280614587E-4	0.030140402041600078	0	0	5.581395348837209	40.88509459578352	HLA-DMB;HLA-DRA;IL12A;HLA-DOB;HLA-DRB1;HSPD1
G-protein-mediated events	6/44	7.468154346855457E-4	0.0331673913639757	0	0	5.454545454545454	39.271049884075076	PLCB4;PDE1C;CAMK4;ITPR1;ITPR3;PLCB1
Interactions of HIV Vpr protein with host cellular proteins	6/44	7.468154346855457E-4	0.03221975161071925	0	0	5.454545454545454	39.271049884075076	RANBP1;NUP155;RCC1;NUP88;RAN;NUP37
Disease	31/674	8.794454386750184E-4	0.036887850344424385	0	0	1.8397626112759642	12.944972700677146	APP;PSMD12;PSMD11;CXCL8;PDE1C;PSMD14;ITPR1;ITPR3;PSMD6;PSMB4;EXOSC4;SERP1;PSMB3;IGF2BP1;RCC1;NUP88;IGF2BP2;RANBP1;XRCC6;NUP155;EGF;GTF2H3;ADAM17;CAMK4;AKT1S1;TCEA1;SPRY2;FGFR4;RAN;RPL26L1;NUP37
APC/C-mediated degradation of cell cycle proteins	8/82	0.001017817094711006	0.04153794089225998	0	0	3.902439024390244	26.888175797868776	CDC20;PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3;ANAPC1
Global genomic nucleotide excision repair (GG-NER)	5/33	0.0012737417323898032	0.050614474102857965	0	0	6.0606060606060606	40.398766449770015	RFC5;RFC3;RFC4;POLD1;GTF2H3
DNA repair	9/105	0.001276849430568721	0.049436990773301756	0	0	3.4285714285714284	22.845804403200876	RFC5;ALKBH2;XRCC6;RFC3;RFC4;PRKDC;POLD1;TCEA1;GTF2H3
mRNA stability regulation by proteins that bind AU-rich elements	8/86	0.001389562119236427	0.05245597000117511	0	0	3.7209302325581395	24.479131548284645	MAPK11;PSMD6;PSMD12;PSMB4;PSMD11;EXOSC4;PSMD14;PSMB3
Activation of NF-kappaB in B cells	7/68	0.0015213964477348994	0.056031917953163375	0	0	4.117647058823529	26.715815618757905	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3;CDC6
Neural crest differentiation	8/91	0.001997670561670906	0.07182101305054925	0	0	3.5164835164835164	21.857665042283042	CDH2;GBX2;DLX5;LHX1;ZIC1;ID1;SNAI1;HDAC9
Protein folding	6/53	0.002010576111795613	0.0706039518328227	0	0	4.528301886792453	28.1177387556033	TUBA1C;TUBA1B;VBP1;PFDN4;CCT7;CCT4
Allograft rejection	5/37	0.0021554386293100927	0.07397073477859636	0	0	5.405405405405405	33.1878974911072	HLA-DMB;HLA-DRA;IL12A;HLA-DOB;HLA-DRB1
Unwinding of DNA	3/11	0.002206288138266319	0.0740332241951587	0	0	10.909090909090908	66.72484091962643	MCM7;MCM5;MCM6
EGFR interaction with phospholipase C-gamma	5/38	0.0024318035074588607	0.07982659339701913	0	0	5.263157894736842	31.679590067224634	PDE1C;EGF;CAMK4;ITPR1;ITPR3
Signaling events mediated by HDAC class II	5/38	0.0024318035074588607	0.07812815523963575	0	0	5.263157894736842	31.679590067224634	TUBA1B;CAMK4;GATA2;HDAC9;RAN
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	7/75	0.0026831856069593736	0.0844085472189303	0	0	3.7333333333333334	22.104135315891362	CDH2;ITGA4;ACTN1;ITGB8;DSG2;ITGA6;ACTN4
HIV life cycle	9/118	0.0028606544429483588	0.0881548614051433	0	0	3.0508474576271185	17.86791311426861	RANBP1;XRCC6;NUP155;RCC1;TCEA1;NUP88;GTF2H3;RAN;NUP37
Nucleotide excision repair	6/58	0.0031926852637912755	0.09641909496649652	0	0	4.137931034482758	23.78024665157176	RFC5;RFC3;RFC4;POLD1;TCEA1;GTF2H3
Antigen processing: cross presentation	7/79	0.003599159183618213	0.10656334053457846	0	0	3.5443037974683542	19.94399247915885	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3;SEC61G
Immune system	39/998	0.003997734755801602	0.11608806694731574	0	0	1.5631262525050098	8.631625979307978	APP;PSMD12;PSMD11;PSMD14;CUL3;ITPR1;ITPR3;IFI30;PVR;CDC20;PSMD6;PSMB4;HLA-DMB;IRAK1;PSMB3;GRAP2;SEC61G;NUP88;HLA-DOB;CTSC;CD55;RAP1GAP2;CD74;CXADR;ITGA4;NUP155;MAPK11;ADAM17;UBE2S;AKT1S1;HLA-DRA;TRIM36;ULBP2;SAE1;HLA-DRB1;ANAPC1;ULBP3;UBE2M;NUP37
EGFR1 pathway	10/152	0.004969244061918933	0.1415765761037281	0	0	2.631578947368421	13.959177764893496	PRPS1;RANBP1;ANXA1;SLC20A1;TUBB;PDCD5;COTL1;LIF;ID3;SPRY2
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	14/255	0.005114125992905357	0.14300611572753866	0	0	2.1960784313725488	11.585958073377828	PSMD12;PSMD11;PSMD14;CUL3;CDC20;PSMD6;PSMB4;PSMB3;UBE2S;SEC61G;TRIM36;SAE1;ANAPC1;UBE2M
Ubiquitin-mediated degradation of phosphorylated Cdc25A	6/64	0.005218196737777777	0.14326321952808077	0	0	3.75	19.708512709886456	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3
Myc active pathway	7/85	0.005395923850282639	0.14549723239154974	0	0	3.2941176470588234	17.202249492199844	TERT;ACTL6A;SNAI1;RCC1;PMAIP1;NME1;HSPD1
Homologous recombination	4/29	0.005583621105065782	0.14791698015174265	0	0	5.517241379310344	28.622994590353443	POLD1;XRCC2;RAD54L;SSBP1
ATR activation in response to replication stress	3/15	0.005648024777015824	0.14704340367748092	0	0	8.0	41.41159513548328	RFC5;RFC3;RFC4
Lagging strand processive biosynthesis	3/15	0.005648024777015824	0.1445511425982016	0	0	8.0	41.41159513548328	POLA2;PRIM1;POLD1
Destabilization of mRNA by AUF1 (hnRNP D0)	6/66	0.0060658909902869	0.15265825658888701	0	0	3.6363636363636362	18.563904874494693	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3
Asthma	4/30	0.006317508693985948	0.15638423160522594	0	0	5.333333333333333	27.01029516014832	HLA-DMB;HLA-DRA;HLA-DOB;HLA-DRB1
Hematopoietic cell lineage	7/88	0.006512934675132359	0.1586214735395139	0	0	3.1818181818181817	16.01716177532536	KITLG;ITGA4;HLA-DRA;ITGA6;CD55;CD22;HLA-DRB1
G1 to S cell cycle control	6/67	0.006525399625507425	0.1564024354685113	0	0	3.5820895522388057	18.025264772633918	POLA2;MCM7;ORC1;PRIM1;MCM5;MCM6
Telomerase regulation	6/67	0.006525399625507425	0.1539586474143158	0	0	3.5820895522388057	18.025264772633918	XRCC6;TERT;DKC1;EGF;WT1;PTGES3
FSH regulation of apoptosis	14/263	0.0066644731926177175	0.15482083878235006	0	0	2.1292775665399235	10.669734018372752	KLF10;CSNK1A1;ACTN1;TUBB;GATA6;ITPR1;PTPRF;ABLIM1;KRT18;WT1;PMAIP1;TLK1;CDK14;CD55
Signaling by EGFR in cancer	8/111	0.006748716593633865	0.1544024553998051	0	0	2.8828828828828827	14.40981023842011	ADAM17;PDE1C;EGF;CAMK4;AKT1S1;ITPR1;SPRY2;ITPR3
Intestinal immune network for IgA production	5/48	0.0067673334453859715	0.15251751496317636	0	0	4.166666666666667	20.815200615542235	HLA-DMB;ITGA4;HLA-DRA;HLA-DOB;HLA-DRB1
Interleukin-4 regulation of apoptosis	14/267	0.0075693810412648015	0.16808478488690956	0	0	2.097378277153558	10.24284879610168	FOXC1;ANXA1;CXCL8;MCM7;ACTN1;GATA6;TNC;POU4F1;HS3ST1;ALDH1A2;ID3;MCM5;MCM6;CTSC
Viral myocarditis	6/71	0.008618199165128973	0.18860117013543115	0	0	3.380281690140845	16.069450579234264	CXADR;HLA-DMB;HLA-DRA;HLA-DOB;CD55;HLA-DRB1
DNA replication initiation	2/6	0.0087524127649488	0.18880204678675266	0	0	13.333333333333332	63.17901162743442	POLA2;PRIM1
Telomere extension by telomerase	2/6	0.0087524127649488	0.18614286302919278	0	0	13.333333333333332	63.17901162743442	TERT;DKC1
E2F-mediated regulation of DNA replication	4/33	0.008894984595890918	0.18654759360826786	0	0	4.848484848484849	22.89584334369705	POLA2;ORC1;PRIM1;CDC6
Cyclin A-Cdk2-associated events at S phase entry	6/72	0.00920869205168462	0.19048116435676404	0	0	3.333333333333333	15.625358175773448	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3
Signaling by NGF	12/221	0.009948625407722927	0.203005734671103	0	0	2.171945701357466	10.01336663312105	PREX1;MAPK11;ADAM17;PDE1C;IRAK1;CAMK4;AKT1S1;ITPR1;ITPR3;ECT2;RTN4;ITGB3BP
Wnt/calcium/cyclic GMP pathway	6/74	0.010475384097409076	0.21090439982783607	0	0	3.2432432432432434	14.78506101352144	WNT10B;PLCB4;FZD5;ITPR1;ITPR3;PLCB1
Phospholipase C-mediated cascade	5/54	0.011068822496125156	0.21992002590985504	0	0	3.7037037037037033	16.680084840121786	PDE1C;CAMK4;ITPR1;ITPR3;FGFR4
Downstream signaling events Of B cell receptor (BCR)	7/98	0.011491958723392615	0.2253617879522448	0	0	2.8571428571428568	12.760307798972494	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3;AKT1S1
ID regulation of gene expression	3/20	0.012902143644594305	0.24977226799150515	0	0	5.999999999999999	26.10217084452193	CXCL8;GATA4;ITGA6
Apoptosis regulation	6/78	0.013370780182839728	0.2555680769125062	0	0	3.076923076923077	13.275949342551398	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3
Phosphatidylinositol signaling system	6/78	0.013370780182839728	0.2523734759510999	0	0	3.076923076923077	13.275949342551398	DGKG;PI4K2B;PLCB4;ITPR1;ITPR3;PLCB1
Signaling by the B cell receptor (BCR)	9/151	0.01380638621809256	0.25737831097925634	0	0	2.3841059602649004	10.210229462233258	PSMD6;PSMD12;PSMB4;PSMD11;PSMD14;PSMB3;AKT1S1;ITPR1;ITPR3
Transport of mature mRNAs derived from intronless transcripts	4/38	0.014554726485956956	0.26801996333896344	0	0	4.2105263157894735	17.80985049987152	NUP155;NUP88;RAN;NUP37
MHC class II antigen presentation	7/103	0.014815468083520505	0.2695344193507947	0	0	2.7184466019417473	11.450324086404363	CD74;HLA-DMB;HLA-DRA;IFI30;HLA-DOB;HLA-DRB1;CTSC
Nuclear beta-catenin signaling and target gene transcription regulation	6/80	0.015010081737718086	0.26982408838040844	0	0	2.9999999999999996	12.597099563402262	CXCL8;TERT;TBL1XR1;CAMK4;IGF2BP1;PITX2
Opioid signaling	6/80	0.015010081737718086	0.26664968734063893	0	0	2.9999999999999996	12.597099563402262	PLCB4;PDE1C;CAMK4;ITPR1;ITPR3;PLCB1
Carbohydrate metabolism	12/235	0.015553028818629312	0.27308225018756116	0	0	2.0425531914893615	8.504169967640886	PRPS1;NUP155;CHSY1;RPE;NUP88;SLC25A10;PYGL;GXYLT2;GPC6;FBP2;HS3ST1;NUP37
Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs)	2/8	0.01580491452517871	0.2743151831381592	0	0	10.0	41.47434341416576	IGF2BP1;IGF2BP2
Bystander B cell activation	2/8	0.01580491452517871	0.27119796514795286	0	0	10.0	41.47434341416576	HLA-DRA;HLA-DRB1
Eosinophils in the chemokine network of allergy	2/8	0.01580491452517871	0.26815079700022304	0	0	10.0	41.47434341416576	HLA-DRA;HLA-DRB1
Formyl peptide interaction with formyl peptide receptors	2/8	0.01580491452517871	0.26517134370022055	0	0	10.0	41.47434341416576	APP;ANXA1
Recycling of eIF2-GDP complex	2/8	0.01580491452517871	0.262257372890328	0	0	10.0	41.47434341416576	EIF2B1;EIF2S2
Antigen processing and presentation	6/81	0.015879860297055945	0.2606368374842878	0	0	2.962962962962963	12.274677394419134	CD74;HLA-DMB;HLA-DRA;IFI30;HLA-DOB;HLA-DRB1
Graft-versus-host disease	4/41	0.01883771080535323	0.3058596055492836	0	0	3.902439024390244	15.500076192637533	HLA-DMB;HLA-DRA;HLA-DOB;HLA-DRB1
Th1/Th2 differentiation pathway	3/23	0.01896828932905573	0.30470337113695906	0	0	5.217391304347825	20.686887009392155	HLA-DRA;IL12A;HLA-DRB1
Elevation of cytosolic calcium levels	2/9	0.019987498286726836	0.31769602539955283	0	0	8.888888888888888	34.779095880349324	ITPR1;ITPR3
Folding of actin by CCT/TriC	2/9	0.019987498286726836	0.31438669180164086	0	0	8.888888888888888	34.779095880349324	CCT7;CCT4
Tat-mediated elongation of the HIV-1 transcript	2/9	0.019987498286726836	0.31114559188616003	0	0	8.888888888888888	34.779095880349324	TCEA1;GTF2H3
Proteasome degradation	5/63	0.02052270675923605	0.3162172163923106	0	0	3.1746031746031744	12.337217012805942	PSMD6;PSMD12;PSMB4;PSMD11;PSMB3
Cytosolic tRNA aminoacylation	3/24	0.021284306818544364	0.32463942723234335	0	0	5.0	19.248926234484543	YARS;EEF1E1;FARSB
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	5/64	0.02181970122725916	0.3294774885316133	0	0	3.125	11.95294372275165	MAPK11;PLCB4;ITPR1;ITPR3;PLCB1
Purine metabolism	9/164	0.022389275608458103	0.3347307541462548	0	0	2.195121951219512	8.339648492736076	PRPS1;POLA2;PKM;PDE1C;PRIM1;POLD1;GMPS;AK4;NME1
PIP2 hydrolysis	3/25	0.02374801151107834	0.3515636998208656	0	0	4.8	17.95323109370892	DGKG;ITPR1;ITPR3
Heart development	4/44	0.02382609847412197	0.3492952300575163	0	0	3.6363636363636362	13.58899536203803	FOXC1;GATA6;GATA4;PITX2
Salivary secretion	6/89	0.024118332393649237	0.3501796337924072	0	0	2.696629213483146	10.044358779564119	PLCB4;ITPR1;ADRB1;ITPR3;PLCB1;KCNN4
cAMP cell motility pathway inferred from amoeba model	5/67	0.026025960231530847	0.3742780947582055	0	0	2.9850746268656714	10.891524682558853	PLCB4;PDE1C;ITPR1;ITPR3;PLCB1
Integrin family cell surface interactions	3/26	0.026359322007969647	0.3754960021890016	0	0	4.615384615384615	16.781230569993895	ITGA4;ITGB8;ITGA6
Interleukin-5 regulation of apoptosis	8/144	0.028475356276450748	0.40184848577047316	0	0	2.222222222222222	7.908258350719363	TRAP1;PSMB4;CXCL8;IRAK1;WT1;ITPR1;ITGA6;CD55
NFAT involvement in hypertrophy of the heart	5/69	0.029098928808491353	0.40684613426686983	0	0	2.898550724637681	10.252330191846333	CSNK1A1;CAMK4;LIF;GATA4;HDAC9
Pentose phosphate pathway	3/27	0.029117852235481113	0.40337575115207785	0	0	4.444444444444444	15.717350284548534	PRPS1;RPE;FBP2
Delta Np63 pathway	4/47	0.029543217073038634	0.40554779800262125	0	0	3.4042553191489358	11.98945056052437	SEC14L2;DLX5;DLX6;ADRM1
B lymphocyte cell surface molecules	2/11	0.02954667996708659	0.40194132207478156	0	0	7.2727272727272725	25.612973778194785	HLA-DRA;HLA-DRB1
CDC6 association with the ORC-origin complex	2/11	0.02954667996708659	0.39835256027054244	0	0	7.2727272727272725	25.612973778194785	ORC1;CDC6
Mechanism of protein import into the nucleus	2/11	0.02954667996708659	0.39482731637434293	0	0	7.2727272727272725	25.612973778194785	RCC1;RAN
Telomerase protein component gene hTERT transcriptional regulation	2/11	0.02954667996708659	0.39136391886228733	0	0	7.2727272727272725	25.612973778194785	TERT;WT1
Protein metabolism	18/442	0.030024456159651908	0.3942341634876033	0	0	1.6289592760180995	5.7107126184395876	TOMM40;VBP1;PMM2;SSR3;C1GALT1;EIF2S2;SRP9;HSPD1;TUBA1C;TUBA1B;SEC61G;EIF2B1;CCT7;PFDN4;ALG10B;UGGT1;RPL26L1;CCT4
Long-term potentiation	5/70	0.03071766872573008	0.3998593084125209	0	0	2.8571428571428568	9.951192175476	PLCB4;CAMK4;ITPR1;ITPR3;PLCB1
BDNF signaling pathway	12/261	0.03187948513164435	0.41143609016053817	0	0	1.839080459770115	6.337089793820507	KLF10;FOXC1;PSMB4;ABLIM1;CDH2;TUBB;CAMK4;SCHIP1;SEMA3A;FHL2;RCC1;GATA2
M phase pathway	6/96	0.033337427807949106	0.4266060677118911	0	0	2.5	8.502686387417974	CDC20;CENPH;CENPK;KNTC1;ITGB3BP;NUP37
Inhibition of replication initiation of damaged DNA by RB1/E2F1	2/12	0.03487854042134841	0.4425764372792949	0	0	6.666666666666666	22.372556843567576	POLA2;PRIM1
Calcium signaling pathway	9/178	0.03531403608615794	0.4443682874174874	0	0	2.022471910112359	6.762083806995292	P2RX5;HTR7;PLCB4;PDE1C;CAMK4;ITPR1;ADRB1;ITPR3;PLCB1
Non-coding RNA metabolism	4/50	0.036004517553649654	0.4493125744298428	0	0	3.1999999999999997	10.637154754552185	NUP155;GEMIN6;NUP88;NUP37
p75 neurotrophin receptor-mediated signaling	7/124	0.03629100572845635	0.4491755627046647	0	0	2.258064516129032	7.488160455296562	APP;PREX1;ADAM17;IRAK1;ECT2;RTN4;ITGB3BP
Phagosome	8/154	0.039973414952522365	0.49073054128706317	0	0	2.0779220779220777	6.689954643152282	TUBA1C;TUBA1B;HLA-DMB;SEC61G;TUBB;HLA-DRA;HLA-DOB;HLA-DRB1
Lck and Fyn tyrosine kinases in initiation of T cell receptor activation	2/13	0.040550197611673826	0.49379676123893124	0	0	6.153846153846154	19.724397693220933	HLA-DRA;HLA-DRB1
Autoimmune thyroid disease	4/52	0.040729689807035306	0.4920146528689865	0	0	3.076923076923077	9.848609148264439	HLA-DMB;HLA-DRA;HLA-DOB;HLA-DRB1
Pancreatic secretion	6/101	0.04115481492961408	0.49320452812474014	0	0	2.376237623762376	7.581182612623305	PLCB4;CTRL;ITPR1;ITPR3;RAB27B;PLCB1
One-carbon metabolism	3/31	0.04160691113161275	0.4946963449506713	0	0	3.8709677419354835	12.307699325969082	DNMT1;SHMT2;MTHFD2
Signaling by FGFR in disease	7/128	0.04194011229491369	0.49476226222905995	0	0	2.1875	6.937683759996735	PDE1C;CAMK4;AKT1S1;ITPR1;SPRY2;ITPR3;FGFR4
Signaling by ERBB2	6/102	0.04284562636137552	0.5015263240750157	0	0	2.352941176470588	7.41212166524008	PDE1C;EGF;CAMK4;AKT1S1;ITPR1;ITPR3
TGF-beta signaling pathway	9/185	0.043390502467234505	0.5039973748117239	0	0	1.945945945945946	6.1054340088349335	KLF10;TRAP1;MAPK11;TERT;EGF;LIF;HDAC9;CTGF;PDK1
Gene expression	33/968	0.044665594022575375	0.5148476868251054	0	0	1.3636363636363635	4.238934248737691	GTF3C2;PSMD12;PSMD11;PSMD14;CTGF;PSMD6;PSMB4;EXOSC4;TRIM28;TAF1B;PSMB3;SEC61G;NUP88;EIF2B1;SF3A3;YARS;NUP155;SSR3;GTF2H3;LSM5;EIF2S2;SRP9;MAPK11;TBL1XR1;TCEA1;SNRPA1;GEMIN6;EEF1E1;RAN;RPL26L1;FARSB;SRSF9;NUP37
Chagas disease	6/104	0.04635649540300602	0.5302902125646901	0	0	2.3076923076923075	7.0878319814862065	MAPK11;CXCL8;PLCB4;IRAK1;IL12A;PLCB1
Adhesion and diapedesis of lymphocytes	2/14	0.04654140207685347	0.5284023844815695	0	0	5.7142857142857135	17.52807425877975	CXCL8;ITGA4
Non-homologous end-joining (NHEJ) pathway	2/14	0.04654140207685347	0.5244590831048414	0	0	5.7142857142857135	17.52807425877975	XRCC6;PRKDC
Amoebiasis	6/105	0.04817693752694388	0.5388679678939648	0	0	2.2857142857142856	6.932285364516084	CXCL8;PLCB4;ACTN1;IL12A;ACTN4;PLCB1
Transport of mature transcript to cytoplasm	4/55	0.048445342258299454	0.5378857853678837	0	0	2.9090909090909087	8.806746415378175	NUP155;NUP88;SRSF9;NUP37
Oncostatin M	13/311	0.04990876795655125	0.5500893402510393	0	0	1.6720257234726688	5.011995055228519	KLF10;RFC3;ANXA1;CXCL8;MCM7;ITGA4;TNC;OSMR;CTGF;PLCB4;KRT18;ITGB8;DSG2
T cell receptor regulation of apoptosis	22/603	0.050371604116618715	0.5511675522905382	0	0	1.4593698175787728	4.361075211105934	WNT10B;PLK3;TRAP1;XRCC6;PSMD12;ANXA1;CXCL8;VBP1;SLC20A1;TUBB;PDCD5;NME1;HSPD1;BCL2L12;CDC20;MRPL3;BAG2;PMAIP1;EEF1E1;ECT2;PFDN4;UBE2M
Association of licensing factors with the pre-replicative complex	2/15	0.05283270093282616	0.5739379741623561	0	0	5.333333333333333	15.683333035361262	ORC1;CDC6
Coagulation intrinsic pathway	2/15	0.05283270093282616	0.5698384172040536	0	0	5.333333333333333	15.683333035361262	F12;C1QBP
Interleukin-17 signaling pathway	2/15	0.05283270093282616	0.5657970099898404	0	0	5.333333333333333	15.683333035361262	KITLG;CXCL8
Pathogenic Escherichia coli infection	4/57	0.05400611450011817	0.5742903725012566	0	0	2.807017543859649	8.192724231142156	TUBA1C;TUBA1B;KRT18;TUBB
Cytokines and inflammatory response	3/35	0.056354567885378765	0.5950727098386149	0	0	3.4285714285714284	9.860886785287258	CXCL8;HLA-DRA;HLA-DRB1
CRMPs in Sema3A signaling	2/16	0.05940541077305161	0.6229317379674161	0	0	5.0	14.116849831533036	DPYSL5;SEMA3A
DNA-PK pathway in nonhomologous end joining	2/16	0.05940541077305161	0.6186356570159167	0	0	5.0	14.116849831533036	XRCC6;PRKDC
Inhibitor of DNA binding (ID) signaling pathway	2/16	0.05940541077305161	0.6143984264884104	0	0	5.0	14.116849831533036	ID1;ID3
Serotonin receptor 2 and ELK-SRF/GATA4 signaling	2/16	0.05940541077305161	0.6102188453558361	0	0	5.0	14.116849831533036	ITPR1;GATA4
Generation of second messenger molecules	3/36	0.06037988610364689	0.6160380271385595	0	0	3.333333333333333	9.356997470103483	GRAP2;HLA-DRA;HLA-DRB1
RAGE pathway	4/60	0.06296617067027598	0.6381135416920585	0	0	2.6666666666666665	7.373753787467152	CXCL8;ID1;ID3;CTGF
Androgen receptor proteolysis and transcription regulation	4/61	0.06611592163711043	0.665566944480245	0	0	2.622950819672131	7.124841151897977	XRCC6;PRKDC;FHL2;PA2G4
Cells and molecules involved in local acute inflammatory response	2/17	0.0662415915707929	0.662415915707929	0	0	4.705882352941176	12.773867020503221	CXCL8;ITGA4
Destabilization of mRNA by KSRP	2/17	0.0662415915707929	0.6580579162624821	0	0	4.705882352941176	12.773867020503221	MAPK11;EXOSC4
G1/S-specific transcription	2/17	0.0662415915707929	0.6537568841300476	0	0	4.705882352941176	12.773867020503221	ORC1;CDC6
HIV-1 elongation complex formation in the absence of HIV-1 Tat	2/17	0.0662415915707929	0.6495117095577746	0	0	4.705882352941176	12.773867020503221	TCEA1;GTF2H3
Integrin beta-5 pathway	2/17	0.0662415915707929	0.6453213114315953	0	0	4.705882352941176	12.773867020503221	ITGA4;ITGB8
Post-chaperonin tubulin folding pathway	2/17	0.0662415915707929	0.6411846363583159	0	0	4.705882352941176	12.773867020503221	TUBA1C;TUBA1B
SUMOylation by RanBP2 regulates transcriptional repression	2/17	0.0662415915707929	0.6371006577827852	0	0	4.705882352941176	12.773867020503221	HDAC9;RAN
TAK1-mediated activation of p38 MAPK	2/17	0.0662415915707929	0.6330683751385904	0	0	4.705882352941176	12.773867020503221	MAPK11;IRAK1
Fatty acyl-CoA biosynthesis	2/18	0.07332402120449992	0.6963476227597163	0	0	4.444444444444444	11.612742279715478	ELOVL2;ELOVL7
Nucleotide di- and triphosphate biosynthesis and interconversion	2/18	0.07332402120449992	0.691995450117468	0	0	4.444444444444444	11.612742279715478	CTPS1;NME1
Thymic stromal lymphopoietin (TSLP) pathway	5/90	0.07506739964971518	0.7040482824290057	0	0	2.222222222222222	5.754153126676802	PSMB4;CXCL8;PSMD11;PDCD5;NME1
ER-associated degradation (ERAD) pathway	2/19	0.08063617099611983	0.7516087543465491	0	0	4.2105263157894735	10.601296667256518	SAE1;UGGT1
Inhibition of T cell receptor signaling by activated Csk	2/19	0.08063617099611983	0.7469976576941163	0	0	4.2105263157894735	10.601296667256518	HLA-DRA;HLA-DRB1
Platelet calcium homeostasis	2/19	0.08063617099611983	0.7424427939276887	0	0	4.2105263157894735	10.601296667256518	ITPR1;ITPR3
Telomeres, telomerase, cellular aging, and immortality	2/19	0.08063617099611983	0.7379431406311573	0	0	4.2105263157894735	10.601296667256518	XRCC6;TERT
Apoptosis	10/242	0.08351055620849174	0.7596442161133887	0	0	1.6528925619834711	4.103772286706262	PSMD6;PSMB4;PSMD12;PSMD11;PSMD14;IRAK1;PSMB3;PMAIP1;DSG2;TNFRSF21
Translation	7/151	0.08519040573794436	0.7702845069718322	0	0	1.8543046357615893	4.5669046944055465	SEC61G;SSR3;EIF2S2;EIF2B1;MRPL13;SRP9;RPL26L1
SIDS susceptibility pathways	4/67	0.08667836668553372	0.7790734148521187	0	0	2.388059701492537	5.840121660964135	CXCL8;GATA2;POU3F2;HSPD1
Hexose transport	3/42	0.08718222910547488	0.778965478989746	0	0	2.8571428571428568	6.970727895708977	NUP155;NUP88;NUP37
Signaling by Hippo	2/20	0.08816218183787267	0.7830876151481632	0	0	4.0	9.714308741076266	MOB1A;WWC1
Sprouty regulation of tyrosine kinase signals	2/20	0.08816218183787267	0.7785081554104546	0	0	4.0	9.714308741076266	EGF;SPRY2
APC/C activator regulation between G1/S and early anaphase	2/21	0.09588684119947874	0.8417972686698424	0	0	3.8095238095238093	8.931758172484527	CDC20;ANAPC1
Inactivation of APC/C via direct inhibition of the APC/C complex	2/21	0.09588684119947874	0.8369313885041207	0	0	3.8095238095238093	8.931758172484527	CDC20;ANAPC1
T cell activation co-stimulatory signal	2/21	0.09588684119947874	0.8321214379954764	0	0	3.8095238095238093	8.931758172484527	HLA-DRA;HLA-DRB1
Hedgehog signaling pathway	4/70	0.09798976602376523	0.84551169540506	0	0	2.2857142857142856	5.309467963642306	WNT10B;ZIC2;CSNK1A1;BMP8B
Long-term depression	4/70	0.09798976602376523	0.8407076516811677	0	0	2.2857142857142856	5.309467963642306	PLCB4;ITPR1;ITPR3;PLCB1
Spliceosome	6/127	0.09931318145472103	0.8472480451786935	0	0	1.889763779527559	4.364365933204153	SF3A3;SNRNP27;SNRPA1;LSM5;U2SURP;SRSF9
Deposition of new CENP-A-containing nucleosomes at the centromere	3/45	0.10215828081331627	0.8666236181354358	0	0	2.6666666666666665	6.0832850553957645	CENPH;CENPK;ITGB3BP
Interleukin-12/STAT4 pathway	3/45	0.10215828081331627	0.8617821454084221	0	0	2.6666666666666665	6.0832850553957645	HLA-DRA;IL12A;HLA-DRB1
Double-strand break repair	2/22	0.10379556080326813	0.8707294267385272	0	0	3.6363636363636362	8.237571185428129	XRCC6;PRKDC
Epstein-Barr virus LMP1 signaling	2/22	0.10379556080326813	0.8659187669222922	0	0	3.6363636363636362	8.237571185428129	CXCL8;IRAK1
Nephrin interactions	2/22	0.10379556080326813	0.8611609714996422	0	0	3.6363636363636362	8.237571185428129	ACTN1;ACTN4
Cell-cell communication	6/129	0.10499814284251867	0.8663781185366295	0	0	1.8604651162790697	4.19313975106073	MAPK11;CDH2;ACTN1;ITGA6;ACTN4;PVR
Pyrimidine metabolism	5/100	0.10576065482120137	0.867927112934859	0	0	2.0	4.4931534226415195	POLA2;PRIM1;POLD1;CTPS1;NME1
Polo-like kinase 1 (PLK1) pathway	3/46	0.10736313441562158	0.8763153133383166	0	0	2.6086956521739126	5.821404549935052	CDC20;TPX2;ECT2
Transfer RNA aminoacylation	3/46	0.10736313441562158	0.87160394068596	0	0	2.6086956521739126	5.821404549935052	YARS;EEF1E1;FARSB
GnRH signaling pathway	5/101	0.10912554395411007	0.8811741784529744	0	0	1.9801980198019802	4.386646099300001	MAPK11;PLCB4;ITPR1;ITPR3;PLCB1
Melanogenesis	5/101	0.10912554395411007	0.8764870817590755	0	0	1.9801980198019802	4.386646099300001	WNT10B;KITLG;PLCB4;FZD5;PLCB1
Signaling by NOTCH1	4/73	0.10995046855934236	0.8784402514529469	0	0	2.191780821917808	4.838849973529832	ADAM17;TBL1XR1;DNER;HDAC9
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	3/47	0.11266904115423244	0.8954223796994262	0	0	2.553191489361702	5.57438450312141	APP;MAPK11;IRAK1
Adherens junction cell adhesion	4/74	0.11407613801901988	0.9018584733440838	0	0	2.1621621621621623	4.693814434937615	ACTN1;SNAI1;ACTN4;PTPRF
E2F transcription factor network	4/74	0.11407613801901988	0.8971612937954166	0	0	2.1621621621621623	4.693814434937615	RANBP1;TRIM28;ORC1;CDC6
Gastric acid secretion	4/74	0.11407613801901988	0.892512789682487	0	0	2.1621621621621623	4.693814434937615	PLCB4;ITPR1;ITPR3;PLCB1
Amino acid metabolism	8/195	0.11692743007563818	0.9101052547124414	0	0	1.641025641025641	3.5219721721211754	PSMD6;PSMB4;PSMD12;PSMD11;PSMD14;PSMB3;PYCR1;SLC25A10
Chondroitin sulfate/dermatan sulfate metabolism	3/48	0.11807273003133849	0.9143067812683134	0	0	2.5	5.341136220470389	CHSY1;GXYLT2;GPC6
HES/HEY pathway	3/48	0.11807273003133849	0.9096419507516383	0	0	2.5	5.341136220470389	ID1;GATA6;GATA4
Post-translational regulation of adherens junction stability and disassembly	3/48	0.11807273003133849	0.9050244789204118	0	0	2.5	5.341136220470389	CDH2;EGF;NME1
TGF-beta regulation of extracellular matrix	19/565	0.11839135332804888	0.9028835531583527	0	0	1.3451327433628317	2.870189888986574	KLF10;PRPS1;DLX2;SLC20A1;SEMA3A;PUS1;TNC;CDC6;TM4SF1;PTPRF;CTGF;SFRP1;PKM;TSPAN13;CDH2;MTHFD2;MCM5;CTSC;CD55
2-LTR circle formation	1/5	0.11891526936765551	0.9023218931917579	0	0	8.0	17.03475249279432	XRCC6
Activation of NOXA and translocation to mitochondria	1/5	0.11891526936765551	0.8978102837257991	0	0	8.0	17.03475249279432	PMAIP1
G-protein signaling through tubby proteins	1/5	0.11891526936765551	0.8933435658963175	0	0	8.0	17.03475249279432	PLCB1
GDP-mannose biosynthesis	1/5	0.11891526936765551	0.8889210729958407	0	0	8.0	17.03475249279432	PMM2
Neuroregulin receptor degredation protein-1 controls ErbB3 receptor recycling	1/5	0.11891526936765551	0.8845421514539893	0	0	8.0	17.03475249279432	EGF
Polo-like kinase 3 (PLK3) pathway	1/5	0.11891526936765551	0.8802061605154893	0	0	8.0	17.03475249279432	PLK3
Sodium-coupled phosphate cotransporters	1/5	0.11891526936765551	0.8759124719276089	0	0	8.0	17.03475249279432	SLC20A1
Sulfide oxidation to sulfate	1/5	0.11891526936765551	0.8716604696366982	0	0	8.0	17.03475249279432	SLC25A10
Endogenous Toll-like receptor signaling	2/24	0.12010982001247623	0.8761634213470488	0	0	3.333333333333333	7.064495959797489	IRAK1;HSPD1
Plexin D1 signaling	2/24	0.12010982001247623	0.8719510972059573	0	0	3.333333333333333	7.064495959797489	ITGA4;ITGA6
Protein export	2/24	0.12010982001247623	0.86777908238679	0	0	3.333333333333333	7.064495959797489	SEC61G;SRP9
Signal transduction of S1P receptor	2/24	0.12010982001247623	0.863646801042091	0	0	3.333333333333333	7.064495959797489	PLCB1;S1PR5
TAK1 activates NF-kappaB by phosphorylation and activation of IKK complex	2/24	0.12010982001247623	0.8595536882409437	0	0	3.333333333333333	7.064495959797489	APP;IRAK1
Arf6 integrin-mediated signaling pathway	3/49	0.12357090514220292	0.8801512583241812	0	0	2.4489795918367343	5.120669772142008	ITGA4;ITGA6;NME1
NGF signaling via TRKA from the plasma membrane	6/136	0.12618182871538566	0.8945284570902927	0	0	1.7647058823529411	3.652996459825553	MAPK11;PDE1C;CAMK4;AKT1S1;ITPR1;ITPR3
Ubiquitin-mediated proteolysis	6/136	0.12618182871538566	0.8903484175711792	0	0	1.7647058823529411	3.652996459825553	CDC20;UBE2S;CUL3;SAE1;ANAPC1;UBE2M
APC/C- and Cdc20-mediated degradation of Nek2A	2/25	0.12848911332067864	0.9024119121591849	0	0	3.1999999999999997	6.566115518322446	CDC20;ANAPC1
RNA polymerase I transcription initiation	2/25	0.12848911332067864	0.898234079232522	0	0	3.1999999999999997	6.566115518322446	TAF1B;GTF2H3
Adrenergic pathway	6/137	0.12936659917835788	0.900200759259541	0	0	1.7518248175182483	3.582665782699951	MAPK11;PLCB4;PDE1C;ITPR1;ITPR3;PLCB1
Focal adhesion	9/233	0.1312932080436446	0.9094162575500154	0	0	1.5450643776824036	3.136978548995244	ITGA4;EGF;ACTN1;TXK;TNC;ITGB8;ITGA6;ACTN4;PELO
Alzheimer's disease	7/169	0.13191541383716612	0.9095537666398212	0	0	1.6568047337278107	3.356014334304675	APP;ADAM17;PLCB4;ITPR1;ITPR3;PLCB1;UQCRH
Capped intron-containing pre-mRNA processing	6/138	0.13258979837071028	0.9100481615444206	0	0	1.7391304347826086	3.5139045905290915	SF3A3;NUP155;NUP88;SNRPA1;SRSF9;NUP37
Systemic lupus erythematosus	6/139	0.13585099063149347	0.9282126509210641	0	0	1.7266187050359711	3.4466704766132605	HLA-DMB;ACTN1;HLA-DRA;ACTN4;HLA-DOB;HLA-DRB1
Physiological and pathological hypertrophy  of the heart	2/26	0.1369999344737361	0.9318464011501869	0	0	3.076923076923077	6.116230250609304	MAPK11;GATA4
Tetrasaccharide linker sequence formation in glycosaminoglycan biosynthesis	2/26	0.1369999344737361	0.9276677177369574	0	0	3.076923076923077	6.116230250609304	GXYLT2;GPC6
YAP1- and WWTR1 (TAZ)-stimulated gene expression	2/26	0.1369999344737361	0.9235263439970602	0	0	3.076923076923077	6.116230250609304	TBL1XR1;CTGF
Messenger RNA processing	8/203	0.1376157591542721	0.9235546503242261	0	0	1.5763546798029555	3.1263682069806755	SF3A3;NUP155;DDX1;NUP88;SNRPA1;GTF2H3;SRSF9;NUP37
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism	3/52	0.14059914501552925	0.9394013671391557	0	0	2.3076923076923075	4.527328570603137	GXYLT2;GPC6;HS3ST1
Signaling events mediated by PTP1B	3/52	0.14059914501552925	0.9352630351253268	0	0	2.3076923076923075	4.527328570603137	CDH2;EGF;SPRY2
Assembly of the ORC complex at the origin of replication	1/6	0.14094786294456849	0.9334704958170983	0	0	6.666666666666666	13.062434822233206	ORC1
Basic mechanisms of SUMOylation	1/6	0.14094786294456849	0.9293942054423511	0	0	6.666666666666666	13.062434822233206	SAE1
ER quality control compartment (ERQC)	1/6	0.14094786294456849	0.9253533610708626	0	0	6.666666666666666	13.062434822233206	UGGT1
Klotho-mediated ligand binding	1/6	0.14094786294456849	0.9213475023649281	0	0	6.666666666666666	13.062434822233206	FGFR4
NF-kappaB activation	1/6	0.14094786294456849	0.9173761769237	0	0	6.666666666666666	13.062434822233206	IRAK1
Phosphorylation of Emi1	1/6	0.14094786294456849	0.9134389401128687	0	0	6.666666666666666	13.062434822233206	CDC20
Proteolysis and signaling pathway of Notch	1/6	0.14094786294456849	0.9095353548987112	0	0	6.666666666666666	13.062434822233206	ADAM17
Signaling by EGFR	1/6	0.14094786294456849	0.9056649916863762	0	0	6.666666666666666	13.062434822233206	EGF
EGFR downregulation	2/27	0.1456305058632748	0.9317884061590888	0	0	2.962962962962963	5.708689324070283	EGF;SPRY2
Proteins and DNA sequences in cardicac structures	2/27	0.1456305058632748	0.9278568095086285	0	0	2.962962962962963	5.708689324070283	GATA4;PITX2
TWEAK regulation of gene expression	2/27	0.1456305058632748	0.9239582514854829	0	0	2.962962962962963	5.708689324070283	CXCL8;MMP16
Amyotrophic lateral sclerosis (ALS)	3/53	0.14644202157094957	0.9252194668290119	0	0	2.2641509433962264	4.349718534458366	MAPK11;TOMM40;NEFL
Signal transduction	31/1020	0.1517326694824849	0.9546513788273008	0	0	1.2156862745098038	2.292340661131648	DGKG;APP;CXCL8;ITPR1;ITPR3;ADRB1;HDAC9;HTR7;OR2W3;IRAK1;GRAP2;DNER;ITGB8;ECT2;CD55;ANXA1;FZD5;ITGA4;EGF;CSNK1A1;GPR55;MOB1A;MAPK11;DEPDC1B;ADAM17;KITLG;CAMK4;AKT1S1;ITGA6;FGFR4;ITGB3BP
Response to elevated platelet cytosolic calcium	4/83	0.15407242259021772	0.9653500336565509	0	0	1.927710843373494	3.605460261308949	APP;EGF;ACTN1;ACTN4
Dual incision reaction in TC-NER	2/28	0.15436955442437558	0.9632149883504426	0	0	2.8571428571428568	5.338302420588211	TCEA1;GTF2H3
PERK-regulated gene expression	2/28	0.15436955442437558	0.9592511406617577	0	0	2.8571428571428568	5.338302420588211	CXCL8;EXOSC4
Calcineurin-dependent NFAT signaling role in lymphocytes	3/55	0.15835797713897543	0.9800022355731676	0	0	2.1818181818181817	4.020866466848246	CSNK1A1;CAMK4;RAN
TAp63 pathway	3/55	0.15835797713897543	0.9760022264483792	0	0	2.1818181818181817	4.020866466848246	TFAP2C;PMAIP1;NOC2L
Cell junction organization	4/84	0.15880894471190304	0.9748028720120878	0	0	1.9047619047619047	3.5048636282938084	CDH2;ACTN1;ITGA6;PVR
ECM-receptor interaction	4/84	0.15880894471190304	0.970856301680055	0	0	1.9047619047619047	3.5048636282938084	ITGA4;TNC;ITGB8;ITGA6
Activation of PKC through G-protein coupled receptors	1/7	0.16243058031155067	0.9889926462517803	0	0	5.7142857142857135	10.385740380401181	PLCB1
Cyanoamino acid metabolism	1/7	0.16243058031155067	0.9850207882347048	0	0	5.7142857142857135	10.385740380401181	SHMT2
Endothelial NOS activation	1/7	0.16243058031155067	0.981080705081766	0	0	5.7142857142857135	10.385740380401181	LYPLA1
FYVE-finger proteins in vesicle transport	1/7	0.16243058031155067	0.9771720170137111	0	0	5.7142857142857135	10.385740380401181	EGF
Gamma-secretase-mediated ErbB4 signaling pathway	1/7	0.16243058031155067	0.9732943502795298	0	0	5.7142857142857135	10.385740380401181	ADAM17
Inactivation of BCL-2 by BH3-only proteins	1/7	0.16243058031155067	0.9694473370373182	0	0	5.7142857142857135	10.385740380401181	PMAIP1
Nectin/Necl  trans heterodimerization	1/7	0.16243058031155067	0.9656306152379587	0	0	5.7142857142857135	10.385740380401181	PVR
Adherens junction actin cytoskeletal organization	2/29	0.16320629383915272	0.966437269400473	0	0	2.758620689655172	5.000662819323756	CDH2;PVR
Association of TriC/CCT with target proteins during biosynthesis	2/29	0.16320629383915272	0.9626621238168774	0	0	2.758620689655172	5.000662819323756	CCT7;CCT4
BARD1 signaling events	2/29	0.16320629383915272	0.9589163567981347	0	0	2.758620689655172	5.000662819323756	XRCC6;PRKDC
CDO in myogenesis	2/29	0.16320629383915272	0.9551996267330257	0	0	2.758620689655172	5.000662819323756	MAPK11;CDH2
Integrin cell surface interactions	4/85	0.16359856361460354	0.9537985755137117	0	0	1.8823529411764706	3.4076981359319904	ITGA4;TNC;ITGB8;ITGA6
MicroRNAs in cardiomyocyte hypertrophy	4/85	0.16359856361460354	0.9501301194540436	0	0	1.8823529411764706	3.4076981359319904	EGF;LIF;GATA4;HDAC9
TGF-beta regulation of skeletal system development	4/85	0.16359856361460354	0.9464897741687791	0	0	1.8823529411764706	3.4076981359319904	ID1;BMP8B;ID3;PITX2
CXCR4 signaling pathway	5/116	0.16540921419064641	0.9533126466712828	0	0	1.7241379310344829	3.1022979127853656	ITGA4;HLA-DRA;ITGA6;PLCB1;HLA-DRB1
Leukocyte transendothelial migration	5/117	0.16951475631185442	0.973259627493917	0	0	1.7094017094017093	3.0338723043827405	MAPK11;ITGA4;ACTN1;TXK;ACTN4
Inositol phosphate metabolism	3/57	0.1705587717216263	0.9755444897714232	0	0	2.1052631578947367	3.723527030473866	PI4K2B;PLCB4;PLCB1
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	2/30	0.17213040735200277	0.9808185475529214	0	0	2.6666666666666665	4.692007752438898	PMM2;ALG10B
CDC42 activity regulation	2/30	0.17213040735200277	0.9771312597801661	0	0	2.6666666666666665	4.692007752438898	SPATA13;NME1
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) biosynthesis	2/30	0.17213040735200277	0.97347159214054	0	0	2.6666666666666665	4.692007752438898	GPC6;HS3ST1
Prolactin regulation of apoptosis	5/118	0.17365979929025083	0.9784563318219357	0	0	1.694915254237288	2.9672153730728783	WT1;F12;SSR3;SSBP1;UQCRH
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	5/119	0.17784346282582597	0.9983034530371644	0	0	1.680672268907563	2.90227149232865	CXADR;ITGA4;ULBP2;PVR;ULBP3
Signaling by NOTCH	5/119	0.17784346282582597	0.9946060328407305	0	0	1.680672268907563	2.90227149232865	ADAM17;TBL1XR1;DNER;TMED2;HDAC9
Activated NOTCH1 signaling in the nucleus	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	ADAM17;DNER
Gluconeogenesis	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	SLC25A10;FBP2
NF-kappaB activation by non-typeable Hemophilus influenzae	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	MAPK11;CXCL8
PD-1 signaling	2/31	0.18113203111493761	0.9982093685531235	0	0	2.5806451612903225	4.40910725152166	HLA-DRA;HLA-DRB1
Stathmin and breast cancer resistance to antimicrotubule agents	2/31	0.18113203111493761	0.9945795163038393	0	0	2.5806451612903225	4.40910725152166	TUBA1C;CAMK4
Interleukin-1 regulation of extracellular matrix	5/120	0.18206485655756022	0.9960794688475215	0	0	1.6666666666666665	2.838987167787887	CXCL8;DLX5;PRKDC;ID1;LIF
ATF2 transcription factor network	3/59	0.18301812654553012	0.9976800400135396	0	0	2.0338983050847457	3.453905245189201	MAPK11;CXCL8;CUL3
RNA degradation	3/59	0.18301812654553012	0.9940912628911888	0	0	2.0338983050847457	3.453905245189201	EXOSC4;LSM5;HSPD1
Cytoskeletal remodeling regulation and cell spreading by IPP complex components	1/8	0.18337711757031785	0.9924711381045878	0	0	5.0	8.481052474133024	ACTN1
Degradation of cysteine and homocysteine	1/8	0.18337711757031785	0.9889265983256428	0	0	5.0	8.481052474133024	SLC25A10
Insulin secretion regulation by fatty acids bound to GPR40 (FFAR1)	1/8	0.18337711757031785	0.9854072865878292	0	0	5.0	8.481052474133024	PLCB1
Integration of provirus	1/8	0.18337711757031785	0.9819129345077304	0	0	5.0	8.481052474133024	XRCC6
Lysosphingolipid and lysophosphatidic acid (LPA) G-protein coupled receptors	1/8	0.18337711757031785	0.9784432774953357	0	0	5.0	8.481052474133024	S1PR5
Proepithelin conversion to epithelin and wound repair control	1/8	0.18337711757031785	0.9749980546872534	0	0	5.0	8.481052474133024	CXCL8
RNA polymerase II C-terminal domain phosphorylation and interaction with capping enzyme	1/8	0.18337711757031785	0.9715770088813332	0	0	5.0	8.481052474133024	GTF2H3
Support of platelet aggregation by Eph kinases and ephrins	1/8	0.18337711757031785	0.9681798864726573	0	0	5.0	8.481052474133024	EPHB1
Fibrin clot formation (clotting cascade)	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	C1QBP;F12
Prothrombin activation intrinsic pathway	2/32	0.1902017379712103	0.9972382789462763	0	0	2.5	4.149174978285558	C1QBP;F12
Syndecan 4 pathway	2/32	0.1902017379712103	0.9937876274620331	0	0	2.5	4.149174978285558	ACTN1;TNC
Signaling by PDGF	5/122	0.1906172284083889	0.9925241892988527	0	0	1.6393442622950818	2.717193281076577	PDE1C;CAMK4;AKT1S1;ITPR1;ITPR3
FGF signaling pathway	3/61	0.19571013951815233	1.0	0	0	1.9672131147540983	3.2087618250165857	CDH2;SPRY2;FGFR4
Glucose metabolism	3/61	0.19571013951815233	1.0	0	0	1.9672131147540983	3.2087618250165857	SLC25A10;PYGL;FBP2
Hemostasis pathway	15/468	0.19664184762842415	1.0	0	0	1.282051282051282	2.08509132976118	DGKG;APP;CXADR;ITGA4;EGF;F12;ACTN1;GATA6;ITPR1;GATA4;ITPR3;ACTN4;GATA2;C1QBP;ITGA6
Interleukin-1 signaling pathway	5/125	0.2037060161721424	1.0	0	0	1.5999999999999999	2.545723874740078	MAPK11;CXCL8;IRAK1;UBE2S;UBE2M
Adrenoceptors	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	ADRB1
Alpha-4 beta-7 integrin signaling	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	ITGA4
Axonogenesis regulation by p75 neurotrophin receptor	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	RTN4
Calcium-activated potassium channels	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	KCNN4
Calcium/calmodulin-dependent protein kinase activation	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CAMK4
Rapid glucocorticoid receptor pathway	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	MAPK11
Type I hemidesmosome assembly	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	ITGA6
Fructose and mannose metabolism	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	PMM2;FBP2
MEF2D role in T cell apoptosis	2/35	0.21773131350006625	1.0	0	0	2.2857142857142856	3.484556533108	HLA-DRA;HLA-DRB1
Cytokine-cytokine receptor interaction	9/265	0.22019037940931238	1.0	0	0	1.3584905660377358	2.055753164224223	IL22RA1;KITLG;CXCL8;EGF;LIF;TNFSF9;IL12A;OSMR;TNFRSF21
Interleukin-12-mediated signaling events	3/65	0.2216910070831208	1.0	0	0	1.8461538461538463	2.7811767260910543	HLA-DRA;IL12A;HLA-DRB1
Wnt signaling pathway	8/231	0.22263248750096837	1.0	0	0	1.3852813852813852	2.081015279851725	WNT10B;SFRP1;PLCB4;FZD5;CSNK1A1;TBL1XR1;PLCB1;HDAC9
Activation of the AP-1 family of transcription factors	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	MAPK11
Deregulation of CDK5 in Alzheimer's disease	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	APP
E2F-enabled inhibition of pre-replication complex formation	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	ORC1
Free radical-induced apoptosis	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	CXCL8
IKK complex recruitment by IRAK1	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	IRAK1
Insulin secretion regulation by acetylcholine	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	PLCB1
Phospholipase C signaling pathway	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	PLCB1
Signal-dependent regulation of myogenesis by corepressor MITR	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	HDAC9
TRAF6-mediated IRF7 activation in TLR7/8 or 9 signaling	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	IRAK1
TSH regulation of gene expression	4/97	0.22465400248636988	1.0	0	0	1.6494845360824741	2.4630001271451514	CXCL8;SCHIP1;ID1;PTPRF
Beta-1 integrin cell surface interactions	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	ITGA4;TNC;ITGA6
HIF-1 transcriptional activity in hypoxia	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	PKM;TERT;GATA2
Jak-STAT signaling pathway	7/199	0.23148950997896622	1.0	0	0	1.4070351758793969	2.0588030227614693	IL22RA1;CXCL8;LIF;SPRY2;IL12A;OSMR;PTPRF
T cell receptor signaling in naive CD4+ T cells	3/67	0.23493078009641188	1.0	0	0	1.7910447761194028	2.594264527179215	GRAP2;HLA-DRA;HLA-DRB1
Activation of NMDA receptor upon glutamate binding and postsynaptic events	2/37	0.2362702199007159	1.0	0	0	2.1621621621621623	3.1195224419228023	CAMK4;NEFL
FRA pathway	2/37	0.2362702199007159	1.0	0	0	2.1621621621621623	3.1195224419228023	CXCL8;LIF
Adipogenesis	5/133	0.23995771281939338	1.0	0	0	1.5037593984962405	2.1463046131585695	WNT10B;LIF;ID3;GATA4;GATA2
Dilated cardiomyopathy	4/100	0.24076340791661854	1.0	0	0	1.5999999999999999	2.2783048601180695	ITGA4;ITGB8;ADRB1;ITGA6
Epithelial cell signaling in Helicobacter pylori infection	3/68	0.2416025942539262	1.0	0	0	1.7647058823529411	2.5066960150114252	MAPK11;ADAM17;CXCL8
Alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	ELOVL2
Apoptotic cleavage of cell adhesion  proteins	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	DSG2
BTG family proteins and cell cycle regulation	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	HOXB9
Cardiac protection against reactive oxygen species	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	GABRA3
Down syndrome cell adhesion molecule (DSCAM) interactions	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	MAPK11
Integrin beta-4 pathway	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	ITGA6
Messenger RNA decay by 3' to 5' exoribonuclease	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	EXOSC4
Monocyte and its surface molecules	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	ITGA4
Purine ribonucleoside monophosphate biosynthesis	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	GMPS
Regulated proteolysis of p75 neurotrophin receptor	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	ADAM17
SUMOylation as a mechanism to modulate CtBP-dependent gene responses	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	SAE1
eIF2 regulation	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	EIF2S2
Interferon signaling	6/168	0.24460711115245393	1.0	0	0	1.4285714285714284	2.011574262248821	NUP155;HLA-DRA;NUP88;IFI30;HLA-DRB1;NUP37
RAC1 activity regulation	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	PREX1;SPATA13
Triglyceride biosynthesis	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	ELOVL2;ELOVL7
Platelet activation, signaling and aggregation	7/205	0.2539329104379569	1.0	0	0	1.3658536585365855	1.8721553664208097	DGKG;APP;EGF;ACTN1;ITPR1;ITPR3;ACTN4
Aurora B signaling	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	CUL3;NCAPG
GAB1 signalosome	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	EGF;AKT1S1
Vitamin A and carotenoid metabolism	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	ALDH1A2;RLBP1
Antiviral mechanism by interferon-stimulated genes	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	NUP155;NUP88;NUP37
Complement and coagulation cascades	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	SERPIND1;F12;CD55
MicroRNA regulation of DNA damage response	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	MCM7;TLK1;PMAIP1
Signaling events mediated by HDAC class I	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	GATA2;HDAC9;RAN
Gastrin-CREB signaling pathway via PKC and MAPK	7/206	0.25773585549622413	1.0	0	0	1.3592233009708736	1.8428621827124072	DGKG;APP;ANXA1;PLCB4;ITPR1;ITPR3;PLCB1
Diabetes pathways	5/137	0.2587049099112584	1.0	0	0	1.45985401459854	1.97382074569392	CXCL8;SERP1;EXOSC4;IGF2BP1;IGF2BP2
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	3/71	0.26179144524840503	1.0	0	0	1.6901408450704225	2.2651387651401085	XRCC6;ITPR1;ITPR3
RIG-I-like receptor signaling pathway	3/71	0.26179144524840503	1.0	0	0	1.6901408450704225	2.2651387651401085	MAPK11;CXCL8;IL12A
Beta-arrestins in GPCR desensitization	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	PLCB1
GABA (A) receptor activation	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	GABRA3
Gamma-aminobutyric acid receptor life cycle	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	GABRA3
Granzyme A-mediated apoptosis pathway	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	NME1
Pyruvate dehydrogenase (PDH) complex regulation	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	PDK1
Serotonin receptors	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	HTR7
Interleukin-4 signaling pathway	4/104	0.26263115463910613	1.0	0	0	1.5384615384615385	2.056930284626031	MAPK11;HLA-DRA;MYBL1;HLA-DRB1
Negative regulation of FGFR signaling	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	SPRY2;FGFR4
PAC1 receptor pathway	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	PLCB4;PLCB1
Fatty acid, triacylglycerol, and ketone body metabolism	6/173	0.265541160824059	1.0	0	0	1.3872832369942194	1.839517344227339	TBL1XR1;ELOVL2;FHL2;ELOVL7;TNFRSF21;CTGF
T cell receptor signaling pathway	5/139	0.26820709009249616	1.0	0	0	1.4388489208633093	1.8935192412132424	MAPK11;GRAP2;HLA-DRA;HLA-DRB1;PDK1
Costimulation by the CD28 family	3/72	0.2685696227705788	1.0	0	0	1.6666666666666665	2.1910751599377134	GRAP2;HLA-DRA;HLA-DRB1
Myocyte adrenergic pathway	3/72	0.2685696227705788	1.0	0	0	1.6666666666666665	2.1910751599377134	ITPR1;ADRB1;PITX2
ERBB1 internalization pathway	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	EGF;SPRY2
Plasma membrane estrogen receptor signaling	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	MAPK11;PLCB1
Advanced glycosylation endproduct receptor signaling	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	APP
CBL-mediated ligand-induced downregulation of EGF receptors	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	EGF
Double stranded RNA-induced gene expression	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	EIF2S2
FGFR4 ligand binding and activation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	FGFR4
Glucose-dependent insulinotropic polypeptide (GIP) biosynthesis, secretion, and inactivation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	GATA4
HIV life cycle early phase	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	XRCC6
Interleukin-22 soluble receptor signaling pathway	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	IL22RA1
Melanocyte development and pigmentation pathway	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	KITLG
N-glycan trimming in the ER and calnexin/calreticulin cycle	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	UGGT1
Organic anion transporters	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	SLC25A10
PIP biosynthesis at the early endosome membrane	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	PI4K2B
p27 phosphorylation regulation during cell cycle progression	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	UBE2M
Influenza infection	5/142	0.2825996879135354	1.0	0	0	1.408450704225352	1.7798928353130294	NUP155;NUP88;RAN;RPL26L1;NUP37
Toll-like receptor signaling pathway regulation	5/142	0.2825996879135354	1.0	0	0	1.408450704225352	1.7798928353130294	MAPK11;CXCL8;IRAK1;IL12A;TMED7
Amine ligand-binding G-protein coupled receptors	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	HTR7;ADRB1
Bladder cancer	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	CXCL8;EGF
VEGF, hypoxia, and angiogenesis	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	EIF2B1;EIF2S2
Beta-3 integrin cell surface interactions	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	TNC;PVR
Insulin secretion regulation by glucagon-like peptide-1	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	ITPR1;ITPR3
PI3K class IB pathway in neutrophils	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	PREX1;PDK1
Voltage-gated potassium channels	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	KCNH3;KCNG3
Glycosaminoglycan metabolism	4/110	0.29606967026845615	1.0	0	0	1.4545454545454544	1.77041524338222	CHSY1;GXYLT2;GPC6;HS3ST1
AKT phosphorylation of cytosolic targets	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	AKT1S1
Complement cascade regulation	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	CD55
DCC-mediated attractive signaling	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	ABLIM1
Glycogen breakdown (glycogenolysis)	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	PYGL
HIV-1 early elongation complex formation	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	GTF2H3
Initiation of the second proteolytic cleavage of Notch receptor by receptor-ligand binding	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	ADAM17
MAP kinase inactivation of SMRT corepressor	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	EGF
Platelet amyloid precursor protein pathway	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	APP
S1P/S1P4 pathway	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	S1PR5
Sema3A-plexin repulsion signaling by inhibiting integrin adhesion	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	SEMA3A
T cell receptor/JNK pathway	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	GRAP2
Visual signal transduction	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	SLC25A22
Gastrin pathway	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	CXCL8;TNC
PI3K events in ERBB2 signaling	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	EGF;AKT1S1
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	4/112	0.30733899532659725	1.0	0	0	1.4285714285714284	1.6854341732739702	TBL1XR1;FHL2;TNFRSF21;CTGF
Signaling by SCF-KIT	3/78	0.309564425132796	1.0	0	0	1.5384615384615385	1.8039831534931936	KITLG;GRAP2;AKT1S1
Integrin-linked kinase signaling	2/45	0.31071849114810757	1.0	0	0	1.7777777777777777	2.077987466447498	ACTN1;SNAI1
Wnt interactions in lipid metabolism and immune response	2/45	0.31071849114810757	1.0	0	0	1.7777777777777777	2.077987466447498	KLF10;IFI30
Oocyte meiosis	4/113	0.31299039884400204	1.0	0	0	1.415929203539823	1.6447189572138212	CDC20;ITPR1;ITPR3;ANAPC1
Adhesion and diapedesis of granulocytes	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CXCL8
Arf6 vesicle-mediated transport	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	NME1
BMP signaling pathway in stem cells	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	DLX5
Erythrocyte differentiation pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	KITLG
Hematopoiesis regulation by cytokines	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CXCL8
Messenger RNA decay by 5' to 3' exoribonuclease	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	LSM5
Mu-calpain pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	ACTN1
Sema3A/PAK-dependent axon repulsion	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	SEMA3A
Spliceosomal assembly	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	SNRPA1
Validated nuclear estrogen receptor beta network	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	UBE2M
Unfolded protein response	3/79	0.3164279982103083	1.0	0	0	1.5189873417721518	1.747837301901023	CXCL8;SERP1;EXOSC4
p73 transcription factor network	3/79	0.3164279982103083	1.0	0	0	1.5189873417721518	1.747837301901023	PLK3;MAPK11;WT1
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	2/46	0.3199619156443703	1.0	0	0	1.7391304347826086	1.981831832838938	EGF;ITGA6
Fas signaling pathway	4/115	0.3243198596460406	1.0	0	0	1.391304347826087	1.5666435186676206	MAPK11;CXCL8;PRKDC;CSNK1A1
LKB1 signaling events	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	BRSK2;AKT1S1
Regulation of transcription by NOTCH1 intracellular domain	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	TBL1XR1;HDAC9
Vascular smooth muscle contraction	4/116	0.32999523901017713	1.0	0	0	1.379310344827586	1.5292097267138929	PLCB4;ITPR1;ITPR3;PLCB1
Amino acid biosynthesis and interconversion (transamination)	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PYCR1
B cell survival pathway	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	CCT4
Cell death signaling by NRIF in the nucleus	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ITGB3BP
Cell-extracellular matrix interactions	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ACTN1
Glyoxylate and dicarboxylate metabolism	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	MTHFD2
Hypoxia-inducible factor in the cardivascular system	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ASPH
Inhibition of platelet activation by aspirin	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PLCB1
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	IRAK1
KIT signaling regulation	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	KITLG
N-glycan precursor substrate biosynthesis	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PMM2
Rap1 signaling	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	RAP1GAP2
Sprouty regulation of FGF signaling	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	SPRY2
p75 neurotrophin receptor signaling via NF-kB	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	IRAK1
Actin cytoskeleton regulation	7/226	0.3366114370123741	1.0	0	0	1.238938053097345	1.3489879890713685	ITGA4;EGF;ACTN1;ITGB8;ITGA6;ACTN4;FGFR4
ATM-dependent DNA damage response	3/82	0.33702536869684624	1.0	0	0	1.4634146341463412	1.5916054733134235	WNT10B;PMAIP1;PDK1
Energy metabolism	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	MYBBP1A;CAMK4
Presenilin action in Notch and Wnt signaling	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	ADAM17;CSNK1A1
Amino acid and oligopeptide SLC transporters	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	SLC25A10;SLC1A5
Deadenylation-dependent mRNA decay	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	EXOSC4;LSM5
FoxO family signaling	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	CSNK1A1;RAN
Glycerolipid metabolism	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	DGKG;AGK
Interleukin-5 signaling pathway	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	HLA-DRA;HLA-DRB1
Activation of BH3-only proteins	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PMAIP1
Beta-arrestin-dependent recruitment of Src kinases in GPCR signaling	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PLCB1
Beta-catenin phosphorylation cascade	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CSNK1A1
Cadmium-induced DNA biosynthesis and proliferation in macrophages	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PLCB1
Cell to cell adhesion signaling	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	ACTN1
Complement activation, classical pathway	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CD55
Endocytotic role of NDK, phosphins and dynamin	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	NME1
Eukaryotic protein translation	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	EIF2S2
Inflammasomes	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	APP
NO2-dependent IL-12 pathway in NK cells	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	IL12A
Nitric oxide metabolism	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	LYPLA1
PIP biosynthesis at the Golgi membrane	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PI4K2B
Renin-angiotensin system	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	THOP1
SHC1 events in EGFR signaling	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	EGF
Synaptic proteins at the synaptic junction	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	NRXN3
Syndecan 3 pathway	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CXCL8
Unblocking of NMDA receptor, glutamate binding and activation	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	NEFL
Metabolism	43/1615	0.35477431811383564	1.0	0	0	1.0650154798761609	1.1036472286654997	DGKG;PI4K2B;PRPS1;DNMT1;SHMT2;RPE;PRIM1;GMPS;ITPR1;FHL2;GATA4;AK4;ITPR3;GXYLT2;UQCRH;CTGF;UGT8;CHSY1;POLD1;COX11;NUP88;GPC6;PDK1;LYPLA1;NUP155;AGK;ELOVL2;PMM2;C1GALT1;PYCR1;CTPS1;ELOVL7;HS3ST1;NME1;POLA2;PLCB4;PKM;MTHFD2;ALDH1A2;PLCB1;ALG10B;FBP2;NUP37
Translation factors	2/50	0.3565901556321914	1.0	0	0	1.5999999999999999	1.6498690882006875	EIF2B1;EIF2S2
Asparagine N-linked glycosylation	3/85	0.3575874776802259	1.0	0	0	1.4117647058823528	1.4518238879557512	PMM2;ALG10B;UGGT1
NOD signaling pathway	3/85	0.3575874776802259	1.0	0	0	1.4117647058823528	1.4518238879557512	MAPK11;CXCL8;IRAK1
Malaria	2/51	0.36564128501908433	1.0	0	0	1.5686274509803921	1.578200034140809	CXCL8;IL12A
Corticosteroids and cardioprotection	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	ANXA1
Downregulation of MTA-3 in ER-negative breast tumors	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	SNAI1
Nicotinic acetylcholine receptor role in the regulation of apoptosis	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	TERT
Pre-NOTCH processing in Golgi	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	TMED2
Serotonin receptor 4/6/7 and NR3C signaling	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	HTR7
Toll receptor cascades	5/159	0.3661646145834816	1.0	0	0	1.2578616352201257	1.2637387170741206	APP;MAPK11;IRAK1;UBE2S;UBE2M
Mitochondrial protein import	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	TOMM40;HSPD1
Pyruvate metabolism	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	PKM;PDK1
Signaling events mediated by stem cell factor receptor (c-Kit)	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	KITLG;GRAP2
Integration of energy metabolism	4/125	0.38116325301323645	1.0	0	0	1.28	1.234595212838566	ITPR1;GATA4;ITPR3;PLCB1
Cell cycle progression regulation by PLK3	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	PLK3
Destabilization of mRNA by butyrate response factor 1 (BRF1)	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	EXOSC4
G-protein-independent seven transmembrane receptor signaling	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	MAPK11
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	NAA10
Mitochondrial gene expression	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	CAMK4
Ras activation upon calcium influx through NMDA receptor	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	NEFL
Resolution of abasic sites (AP sites)	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	POLD1
Signaling by constitutively active EGFR	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	EGF
TP53 network	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	PMAIP1
Neurotrophin signaling pathway	4/126	0.3868363211750107	1.0	0	0	1.2698412698412698	1.2060363404673988	MAPK11;IRAK1;CAMK4;PDK1
Kit receptor signaling pathway	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	KITLG;SNAI1
4-1BB-dependent immune response	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	TNFSF9
Chondroitin sulfate biosynthesis	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	CHSY1
Dual incision reaction in GG-NER	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	GTF2H3
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) degradation	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	GPC6
Interleukin-3 regulation of hematopoietic cells	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	CXCL8
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	EIF2S2
Urea cycle and metabolism of amino groups	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	PYCR1
Protein processing in the endoplasmic reticulum	5/166	0.40090416687703195	1.0	0	0	1.2048192771084336	1.1012444163628623	BAG2;SEC61G;SSR3;HSPBP1;UGGT1
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	8/280	0.4012477326520312	1.0	0	0	1.1428571428571428	1.0436300060175148	ADAM17;IRAK1;NUP155;HLA-DRA;NUP88;IFI30;HLA-DRB1;NUP37
Basal cell carcinoma	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	WNT10B;FZD5
RNA polymerase I transcription	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	TAF1B;GTF2H3
Thromboxane A2 receptor signaling	2/56	0.41009437639646396	1.0	0	0	1.4285714285714284	1.273382799199648	MAPK11;EGF
Signaling by ERBB4	3/93	0.41184736294433893	1.0	0	0	1.2903225806451613	1.1446483568607568	ADAM17;EGF;AKT1S1
Biosynthesis of unsaturated fatty acids	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	ELOVL2
Cytosolic sensors of pathogen-associated DNA	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	APP
PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	PLCB1
Presynaptic function of kainate receptors	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	PLCB1
Prion pathway	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	APLP1
p38 MK2 pathway	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	MAPK11
Cell surface interactions at the vascular wall	3/94	0.418539889978251	1.0	0	0	1.276595744680851	1.1118932898382732	CXADR;ITGA4;ITGA6
PI3K cascade	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	AKT1S1;FGFR4
Class B GPCRs (secretin family receptors)	3/95	0.42520717958043197	1.0	0	0	1.263157894736842	1.0802257862809745	WNT10B;FZD5;CD55
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	3/95	0.42520717958043197	1.0	0	0	1.263157894736842	1.0802257862809745	GTF3C2;TAF1B;GTF2H3
Transport of inorganic cations/anions and amino acids/oligopeptides	3/95	0.42520717958043197	1.0	0	0	1.263157894736842	1.0802257862809745	SLC20A1;SLC25A10;SLC1A5
CCR3 signaling in eosinophils	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	PLCB1
Glycosaminoglycan biosynthesis: chondroitin sulfate	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	CHSY1
RNA polymerase II promoter escape	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	GTF2H3
TRAF6 mediated NF-kB activation	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	APP
Antigen-activated B-cell receptor generation of second messengers	6/211	0.43300780457193566	1.0	0	0	1.1374407582938388	0.9520373763714076	MAPK11;ITPR1;HLA-DRA;ITPR3;CD22;HLA-DRB1
Caspase cascade in apoptosis	2/59	0.43602582146324703	1.0	0	0	1.3559322033898304	1.1254966967419524	APP;KRT18
Interferon-gamma signaling pathway	3/97	0.4384603644337263	1.0	0	0	1.2371134020618557	1.0199825075033913	HLA-DRA;IFI30;HLA-DRB1
SLC-mediated transmembrane transport	7/251	0.43858181231640664	1.0	0	0	1.1155378486055776	0.9194362358749065	NUP155;SLC20A1;SLC41A2;NUP88;SLC25A10;SLC1A5;NUP37
Blood clotting cascade	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	F12
Eicosanoid metabolism	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	PLCB1
FGFR ligand binding and activation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	FGFR4
Hypoxia and p53 in the cardiovascular system	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	FHL2
Incretin biosynthesis, secretion, and inactivation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	GATA4
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	MAPK11
Modulation of interferon signaling by chaperones	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	WT1
Proximal tubule bicarbonate reclamation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	SLC25A10
Signaling events mediated by PRL	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	TUBA1B
Signaling events mediated by the hedgehog family	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	STIL
Potassium channels	3/99	0.45159604781162715	1.0	0	0	1.2121212121212122	0.9635966039626941	KCNH3;KCNG3;KCNN4
HIV genome transcription	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	TCEA1;GTF2H3
NF-kappaB signaling pathway	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	IRAK1
Sulfur amino acid metabolism	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	SLC25A10
Integrin-mediated cell adhesion	3/100	0.4581166423834544	1.0	0	0	1.2	0.9367577395196145	ITGA4;ITGB8;ITGA6
p53 signaling pathway	4/139	0.4596056772594075	1.0	0	0	1.1510791366906474	0.8948332437112545	PLK3;LIF;PMAIP1;POU4F1
Shigellosis	2/62	0.46132803795917154	1.0	0	0	1.2903225806451613	0.9982527870331739	MAPK11;CXCL8
Signaling events mediated by focal adhesion kinase	2/62	0.46132803795917154	1.0	0	0	1.2903225806451613	0.9982527870331739	ACTN1;ACTN4
RNA polymerase II transcription	3/101	0.4646041358021239	1.0	0	0	1.188118811881188	0.9107757110849387	TCEA1;GTF2H3;SRSF9
TNF-alpha signaling pathway	3/101	0.4646041358021239	1.0	0	0	1.188118811881188	0.9107757110849387	TRAP1;ADAM17;PYGL
Alpha-9 beta-1 integrin pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	TNC
Basigin interactions	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	ITGA6
C-Myc pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	ACTL6A
Ck1/Cdk5 regulation by type 1 glutamate receptors	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	PLCB1
Corticotropin releasing hormone pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	CXCL8
G0 and early G1 pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	CDC6
Ghrelin pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	CXCL8
IGF1 receptor signaling through beta-arrestin	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	MAPK11
Ligand-gated ion channel transport	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	GABRA3
Metal ion solute carrier family (SLC) transporters	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	SLC41A2
Regulatory RNA pathways	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	RAN
SHC1 events in ERBB2 signaling	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	EGF
Folate metabolism	2/63	0.46961389196045544	1.0	0	0	1.2698412698412698	0.9598024487193709	MTHFD2;SHMT2
Transcription	5/181	0.4743254811903252	1.0	0	0	1.1049723756906076	0.8241563798437236	GTF3C2;TAF1B;TCEA1;GTF2H3;SRSF9
MAPK cascade role in angiogenesis	2/64	0.47782308073315993	1.0	0	0	1.25	0.9231434237408449	MAPK11;SEMA3A
Validated nuclear estrogen receptor alpha network	2/64	0.47782308073315993	1.0	0	0	1.25	0.9231434237408449	POU4F1;UBE2M
ALK1 pathway	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	ID1
Glycosaminoglycan biosynthesis: heparan sulfate	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	HS3ST1
Interleukin-27-mediated signaling events	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	IL12A
PGC-1a regulation	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	CAMK4
Segmentation clock	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	ADAM17
Electron transport chain	3/105	0.4902008924525257	1.0	0	0	1.1428571428571428	0.8147885569156508	ATP5S;COX11;UQCRH
Fibroblast growth factor receptor pathway	3/105	0.4902008924525257	1.0	0	0	1.1428571428571428	0.8147885569156508	MAPK11;SPRY2;FGFR4
Retinoblastoma protein regulation	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	MAPK11;DNMT1
Semaphorin interactions	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	DPYSL5;SEMA3A
ADP signalling through P2Y purinoceptor 12	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	PLCB1
BAD phosphorylation regulation	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	KITLG
Cell cycle: G2/M checkpoint	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	PRKDC
Control of gene expression by vitamin D receptor	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	ACTL6A
Mammalian calpain regulation of cell motility	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	EGF
RNA polymerase III transcription initiation from type 2 promoter	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	GTF3C2
RORA activates circadian expression	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	TBL1XR1
G-protein beta-gamma signalling	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	PLCB1
Messenger RNA capping	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	GTF2H3
Multi-step regulation of transcription by PITX2	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	PITX2
Nitric oxide stimulation of guanylate cyclase	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	ITPR1
TRAIL signaling pathway	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	DAP3
G alpha i pathway	3/108	0.5089992912119659	1.0	0	0	1.111111111111111	0.7503429499371738	MAPK11;ITPR1;ITPR3
Messenger RNA splicing: major pathway	2/68	0.5098678748711668	1.0	0	0	1.176470588235294	0.7924748890682	SNRPA1;SRSF9
Calcium regulation in the cardiac cell	4/149	0.5135091490299979	1.0	0	0	1.0738255033557047	0.7156912029758662	CAMK4;ITPR1;ADRB1;ITPR3
Matrix metalloproteinases	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	MMP16
Pentose and glucuronate interconversions	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	RPE
AP-1 transcription factor network	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	CXCL8;GATA2
G alpha q pathway	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	ITPR1;ITPR3
Nucleotide metabolism	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	GMPS;NME1
Epidermal growth factor receptor (EGFR) pathway	3/111	0.5274287408162633	1.0	0	0	1.0810810810810811	0.6916124446023388	MAPK11;EGF;SPRY2
Activation of kainate receptors upon glutamate binding	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PLCB1
Activation of matrix metalloproteinases	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	MMP16
Apoptosis intrinsic pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PMAIP1
Nectin adhesion pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PVR
Nuclear events mediated by MAP kinases	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	MAPK11
O-glycan biosynthesis	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	C1GALT1
PDGFA signaling pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	EGF
TNFR1 signaling pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PRKDC
p38-alpha and p38-beta regulation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	MAPK11
Alpha-6 beta-4 integrin signaling pathway	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	ITGA6
Amino acid transport across the plasma membrane	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	SLC1A5
CD28 co-stimulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	GRAP2
CD40/CD40L signaling	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	MAPK11
Prostaglandin biosynthesis and regulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	ANXA1
Integrin signaling pathway	4/155	0.5446402358822579	1.0	0	0	1.032258064516129	0.6272307818732501	MAPK11;TSPAN13;ACTN1;ITGB3BP
Cap-dependent translation initiation	2/73	0.548068839980631	1.0	0	0	1.095890410958904	0.6590184981053064	EIF2S2;RPL26L1
Myc repressed pathway	2/73	0.548068839980631	1.0	0	0	1.095890410958904	0.6590184981053064	SFRP1;ITGA6
RANKL regulation of apoptosis and immune response	2/74	0.5554545611303542	1.0	0	0	1.0810810810810811	0.635641590695438	LHX1;PRMT3
Seven transmembrane receptor signaling through beta-arrestin	2/74	0.5554545611303542	1.0	0	0	1.0810810810810811	0.635641590695438	MAPK11;PDE1C
Glycine, serine and threonine metabolism	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	SHMT2
Hypothetical network for drug addiction	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	CAMK4
Serotonin HTR1 group and FOS pathway	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	ITPR1
G alpha (i) signaling events	5/199	0.5581355275127633	1.0	0	0	1.0050251256281406	0.5860838846676963	APP;ANXA1;CXCL8;GPR55;S1PR5
Glycolysis and gluconeogenesis	2/75	0.5627543403864517	1.0	0	0	1.0666666666666667	0.6132395588377343	PKM;FBP2
Neuronal system	7/283	0.5645277839293491	1.0	0	0	0.989399293286219	0.56570455769013	KCNH3;KCNG3;CAMK4;GABRA3;NEFL;KCNN4;PLCB1
PIP biosynthesis at the plasma membrane	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PI4K2B
Syndecan 2 pathway	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	CXCL8
p53 activity regulation	3/118	0.5688860293435293	1.0	0	0	1.0169491525423728	0.5736357608562849	TRIM28;CSNK1A1;PMAIP1
GPCR ligand binding	10/410	0.576425056819611	1.0	0	0	0.975609756097561	0.5374731166507691	WNT10B;APP;HTR7;ANXA1;CXCL8;FZD5;GPR55;ADRB1;S1PR5;CD55
G alpha (12/13) signaling events	2/77	0.5770948361053473	1.0	0	0	1.0389610389610389	0.571167444479923	PREX1;ECT2
Transcriptional regulation of white adipocyte differentiation	2/77	0.5770948361053473	1.0	0	0	1.0389610389610389	0.571167444479923	WNT10B;TBL1XR1
Cysteine and methionine metabolism	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	DNMT1
EGF receptor transactivation by GPCRs in cardiac hypertrophy	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	EGF
EPO receptor signaling	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	PDK1
Interleukin-7 interactions in immune response	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	CXCL8
N-cadherin signaling events	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	CDH2
TOR signaling	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	AKT1S1
G alpha s pathway	3/120	0.5803125850880102	1.0	0	0	1.0	0.5441883808106572	MAPK11;PDE1C;PYGL
Notch signaling pathway	3/121	0.5859537465440404	1.0	0	0	0.9917355371900827	0.5300969487595464	ADAM17;DNER;MAGEA1
Arf6 signal transduction regulation	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	EGF
Basal transcription factors	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	GTF2H3
Base excision repair	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	POLD1
EGF receptor (ErbB1) signaling pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	EGF
Interleukin-2/PI3K pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	TERT
Interleukin-7 signaling pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	NMI
Linoleic acid metabolism	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	ELOVL2
PIK3C1/AKT pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	PRKDC
fMLP induced chemokine gene expression in HMC-1 cells	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	PLCB1
Fc epsilon receptor I signaling pathway	2/79	0.591088531821221	1.0	0	0	1.0126582278481011	0.5324450357053537	MAPK11;PDK1
Glycerophospholipid metabolism	2/79	0.591088531821221	1.0	0	0	1.0126582278481011	0.5324450357053537	DGKG;LYPLA1
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	2/79	0.591088531821221	1.0	0	0	1.0126582278481011	0.5324450357053537	AKT1S1;SNAI1
Rho GTPase cycle	3/123	0.5970899258295942	1.0	0	0	0.975609756097561	0.5031098023441123	PREX1;DEPDC1B;ECT2
Apoptosis modulation and signaling	2/80	0.5979550492708914	1.0	0	0	1.0	0.5142396963001198	IRAK1;PMAIP1
Glycogen metabolism	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	PYGL
PI3K/PLC/TRK pathway	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	CAMK4
Phospholipids as signaling intermediaries	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	PLCB1
Signaling to ERKs	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	MAPK11
MAP kinase signaling pathway	2/81	0.6047346486005095	1.0	0	0	0.9876543209876543	0.49675606372126246	MAPK11;MAP3K9
Factors involved in megakaryocyte development and platelet production	3/125	0.608029043614279	1.0	0	0	0.96	0.4776313238922669	GATA6;GATA4;GATA2
ALK in cardiac myocytes	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	GATA4
PI3K/AKT activation	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	AKT1S1
Platelet homeostasis	2/82	0.611427375574375	1.0	0	0	0.975609756097561	0.4799600929754372	ITPR1;ITPR3
Regular glucocorticoid receptor pathway	2/82	0.611427375574375	1.0	0	0	0.975609756097561	0.4799600929754372	MAPK11;CXCL8
T cell signal transduction	2/83	0.6180333278447322	1.0	0	0	0.963855421686747	0.4638196572792209	MAPK11;GRAP2
BMAL1-CLOCK/NPAS2 activates circadian expression	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	TBL1XR1
ERBB4 signaling events	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	ADAM17
Signal transduction through IL-1R	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	IRAK1
Striated muscle contraction	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	ACTN4
p38 alpha/beta MAPK downstream pathway	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	MAPK11
Differentiation pathway in PC12 cells	2/84	0.6245526523539249	1.0	0	0	0.9523809523809523	0.44830442071927945	PLCB4;PLCB1
E-cadherin nascent AJ-like junctions pathway	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	NME1
FAS pathway and stress induction of heat shock protein regulation	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	PRKDC
FRS2-mediated cascade	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	FGFR4
HIV-1 transcription initiation	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	GTF2H3
Tricarboxylic acid (TCA) cycle	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	PDK1
C-Myb transcription factor network	2/85	0.6309855429295065	1.0	0	0	0.9411764705882353	0.433385720533733	KITLG;TRIM28
Nuclear signaling by ErbB4	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	ADAM17
Pyruvate metabolism and citric acid (TCA) cycle	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	PDK1
Non-class A, B, C GPCRs	2/86	0.6373322377682995	1.0	0	0	0.9302325581395349	0.4190364586262058	HTR7;GPR55
Progesterone-mediated oocyte maturation	2/86	0.6373322377682995	1.0	0	0	0.9302325581395349	0.4190364586262058	MAPK11;ANAPC1
Alpha-M beta-2 integrin signaling	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	CTGF
Insulin biosynthesis and processing	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	SRP9
Androgen receptor signaling, proteolysis, and transcription regulation	2/88	0.649768200720319	1.0	0	0	0.9090909090909091	0.3919450854280717	FHL2;RAN
Tight junction	3/133	0.649776187680017	1.0	0	0	0.9022556390977443	0.38898703942792145	MAGI1;ACTN1;ACTN4
Eukaryotic transcription initiation	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	GTF2H3
Netrin-1 signaling	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	ABLIM1
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP)	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	EGF
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	3/135	0.6597044758695414	1.0	0	0	0.8888888888888888	0.36974516273053687	CXCL8;ITPR1;PMAIP1
Cell differentiation by G alpha (i/o) pathway inferred from mouse Neuro2A model	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	PDK1
Cleavage of growing transcript in the termination region	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	SRSF9
Growth hormone receptor signaling	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	ADAM17
Mitotic prometaphase	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	CDC20
Oxidative phosphorylation	3/136	0.6645919082134366	1.0	0	0	0.8823529411764706	0.36051361637596113	ATP5S;COX11;UQCRH
Huntington's disease	4/184	0.6787950265140977	1.0	0	0	0.8695652173913043	0.33690093263352294	PLCB4;ITPR1;PLCB1;UQCRH
Amino sugar and nucleotide sugar metabolism	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	PMM2
Interleukin-3 signaling pathway	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	CXCL8
RNA polymerase III transcription	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	GTF3C2
Signaling by FGFR mutants	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	FGFR4
ERBB signaling pathway	2/94	0.6850442087819228	1.0	0	0	0.8510638297872339	0.3219335356890655	EGF;PDK1
RhoA activity regulation	1/46	0.688372038071095	1.0	0	0	0.8695652173913043	0.32471811668930733	ECT2
G-protein signaling pathways	2/95	0.6906320962251579	1.0	0	0	0.8421052631578947	0.31170359515928925	PDE1C;ITPR1
Insulin signaling pathway	6/277	0.6945351723236539	1.0	0	0	0.8664259927797833	0.3158230821449011	MAPK11;PYGL;MAP3K9;EIF2B1;PTPRF;FBP2
Regulation of NFAT transcription factors	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	CXCL8
Chemokine signaling pathway	4/189	0.6989076620194956	1.0	0	0	0.8465608465608465	0.3032691179593534	PREX1;CXCL8;PLCB4;PLCB1
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	2/97	0.7015629289067601	1.0	0	0	0.8247422680412371	0.29232550701224613	C1QBP;CTSC
Transmission across chemical synapses	4/190	0.7028199133421791	1.0	0	0	0.8421052631578947	0.29697228528513436	CAMK4;GABRA3;NEFL;PLCB1
ATM pathway	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	TRIM28
Activation of chaperones by IRE1 alpha	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	SERP1
Diurnally regulated genes with circadian orthologs	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	SF3A3
N-glycan biosynthesis	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	ALG10B
Wnt signaling pathway and pluripotency	2/98	0.7069070769803031	1.0	0	0	0.8163265306122448	0.283147799645867	WNT10B;FZD5
Ceramide signaling pathway	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	EGF
G alpha 12 pathway	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	MAPK11
Granule cell survival pathway	2/99	0.712171216084855	1.0	0	0	0.8080808080808081	0.27429246420172493	PLCB4;PLCB1
Senescence and autophagy	2/99	0.712171216084855	1.0	0	0	0.8080808080808081	0.27429246420172493	CXCL8;AKT1S1
Aquaporin-mediated transport	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	MYO5B
Phosphatidylinositol metabolism	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	PI4K2B
Type 2 diabetes mellitus	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	PKM
Amyloids	1/51	0.7255104548045064	1.0	0	0	0.7843137254901961	0.25167042845488546	APP
Type I interferon (interferon-alpha/beta) pathway	1/51	0.7255104548045064	1.0	0	0	0.7843137254901961	0.25167042845488546	PTPRF
Post-translational protein modification	4/196	0.7255223635638707	1.0	0	0	0.8163265306122448	0.2619292915074513	PMM2;C1GALT1;ALG10B;UGGT1
Apoptotic execution  phase	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	DSG2
Drug metabolism: other enzymes	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	GMPS
Endometrial cancer	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	EGF
Interleukin-2 receptor beta chain in T cell activation	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	NMI
Taste transduction	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	ITPR3
Vitamin B12 metabolism	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	SHMT2
Integrated breast cancer pathway	3/152	0.7358789564635041	1.0	0	0	0.7894736842105262	0.24212339613573824	PLK3;ANXA1;RAD54L
Androgen receptor regulation of biosynthesis and transcription	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	GATA2
GABA A and B receptor activation	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	GABRA3
JNK/MAPK pathway	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	MAP3K9
Starch and sucrose metabolism	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	PYGL
Thrombin signaling through protease-activated receptors	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	PLCB1
Arginine and proline metabolism	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	PYCR1
Binding of chemokines to chemokine receptors	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	CXCL8
Non-small cell lung cancer	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	EGF
RANKL signaling pathway	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	FHL2
T cell receptor signaling in naive CD8+ T cells	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	GRAP2
Vibrio cholerae infection	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	SEC61G
Transmembrane transport of small molecules	9/432	0.7559446643310022	1.0	0	0	0.8333333333333333	0.2331559173423959	NUP155;SLC20A1;MYO5B;SLC41A2;GABRA3;NUP88;SLC25A10;SLC1A5;NUP37
Activation of mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	EIF2S2
Keratinocyte differentiation	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	EGF
Pre-NOTCH expression and processing	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	TMED2
SHP2 signaling	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	EGF
HIV-1 Nef as negative effector of Fas and TNF	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	PRKDC
Tryptophan metabolism	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	ALDH1A2
Ephrin receptor B forward pathway	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	EPHB1
Natural killer cell receptor signaling pathway	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	MAPK11
Clathrin derived vesicle budding	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	TPD52
Ion channel transport	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	GABRA3
Circadian rhythm	1/62	0.7923971144117075	1.0	0	0	0.6451612903225806	0.15012426177080712	TBL1XR1
Tricarboxylic acid (TCA) cycle and respiratory electron transport	2/117	0.7940533715416223	1.0	0	0	0.6837606837606838	0.15767835995062773	UQCRH;PDK1
O-linked glycosylation of mucins	1/63	0.7976032864598676	1.0	0	0	0.6349206349206349	0.143583453909114	C1GALT1
Endothelins	1/64	0.8026791537609369	1.0	0	0	0.625	0.13737512770713134	PLCB1
ERK1/ERK2 MAPK pathway	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	TERT
Glioma	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	EGF
LPA receptor mediated events	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	CXCL8
Retinol metabolism	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	ALDH1A2
Thyroid-stimulating hormone signaling pathway	1/66	0.8124529129968876	1.0	0	0	0.6060606060606061	0.12587716344981695	PLCB1
Neuroactive ligand-receptor interaction	5/272	0.813362730123577	1.0	0	0	0.7352941176470588	0.15189566648647154	P2RX5;HTR7;GABRA3;ADRB1;S1PR5
AMPK signaling	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	PLCB1
G alpha (s) signaling events	2/125	0.8233393070687913	1.0	0	0	0.64	0.12440760480345983	HTR7;ADRB1
Pathways in cancer	6/325	0.8256100923237046	1.0	0	0	0.7384615384615385	0.14151334899711557	WNT10B;KITLG;CXCL8;FZD5;EGF;ITGA6
Pancreatic cancer	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	EGF
Signaling events mediated by VEGFR1 and VEGFR2	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	MAPK11
Interleukin-6 signaling pathway	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	MAPK11
Melanoma	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	EGF
Sphingolipid metabolism	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	UGT8
Signaling by GPCR	20/977	0.8504907329054594	1.0	0	0	0.8188331627430911	0.13260328619062806	DGKG;WNT10B;APP;ANXA1;CXCL8;FZD5;PDE1C;GPR55;ITPR1;ITPR3;ADRB1;PREX1;HTR7;PLCB4;OR2W3;CAMK4;PLCB1;S1PR5;ECT2;CD55
RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	APP
VEGF signaling pathway	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	MAPK11
Complement cascade	1/77	0.8581837738781999	1.0	0	0	0.5194805194805194	0.07944779935587648	CD55
Mitochondrial pathway of apoptosis: caspases	1/77	0.8581837738781999	1.0	0	0	0.5194805194805194	0.07944779935587648	HSPD1
Natural killer cell-mediated cytotoxicity	2/137	0.8602852133033936	1.0	0	0	0.583941605839416	0.08787813216937412	ULBP2;ULBP3
Peroxisome	1/78	0.8617428383211508	1.0	0	0	0.5128205128205128	0.07630686371389282	NUDT19
Peptide G-protein coupled receptors	3/192	0.8620645380791544	1.0	0	0	0.625	0.09276571309977663	APP;CXCL8;ANXA1
Cardiac muscle contraction	1/80	0.868595756144096	1.0	0	0	0.5	0.07043872237547145	UQCRH
EGF/EGFR signaling pathway	2/141	0.8709387333892648	1.0	0	0	0.5673758865248226	0.07840206816686517	EGF;SPRY2
Respiratory electron transport, ATP biosynthesis by chemiosmotic coupling, and heat production by uncoupling proteins	1/81	0.8718940108877108	1.0	0	0	0.49382716049382713	0.06769748622604009	UQCRH
SMAD2/3 nuclear pathway	1/82	0.8751096392159449	1.0	0	0	0.4878048780487805	0.0650761456161355	DLX1
Small cell lung cancer	1/84	0.8813012287674056	1.0	0	0	0.47619047619047616	0.060169426005052117	ITGA6
Endocytosis	3/201	0.8818404296234015	1.0	0	0	0.5970149253731343	0.07507113918653993	EGF;ADRB1;FGFR4
Mitotic G2-G2/M phases	1/87	0.8900189133928805	1.0	0	0	0.45977011494252873	0.05356899562230545	TUBB
Prostate cancer	1/89	0.8954726961455193	1.0	0	0	0.449438202247191	0.04961957214050512	EGF
Myometrial relaxation and contraction pathways	2/155	0.9026055871684786	1.0	0	0	0.5161290322580645	0.05288753627142147	ITPR1;ITPR3
Developmental biology	7/420	0.90366568620665	1.0	0	0	0.6666666666666666	0.06753053542126702	WNT10B;MAPK11;ABLIM1;CDH2;DPYSL5;TBL1XR1;SEMA3A
Extracellular matrix organization	1/93	0.9055837893531324	1.0	0	0	0.43010752688172044	0.04265611705062928	MMP16
Axon guidance	5/325	0.9118663792284842	1.0	0	0	0.6153846153846154	0.05677650070516051	SEMA6B;ABLIM1;DPYSL5;SEMA3A;EPHB1
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	1/96	0.9125210926536497	1.0	0	0	0.41666666666666663	0.038143366064902956	SLC41A2
ERBB1 downstream pathway	1/106	0.9321749795107209	1.0	0	0	0.3773584905660377	0.02650367383491708	EGF
Cytoplasmic ribosomal proteins	1/108	0.9355414383081698	1.0	0	0	0.37037037037037035	0.02467771810747774	RPL26L1
Signaling by insulin receptor	1/109	0.9371615997155951	1.0	0	0	0.3669724770642202	0.023816347377169814	FGFR4
Signaling by interleukins	1/109	0.9371615997155951	1.0	0	0	0.3669724770642202	0.023816347377169814	IRAK1
Leptin influence on immune response	1/110	0.9387411164371052	1.0	0	0	0.3636363636363636	0.022987468775059167	LIF
mTOR signaling pathway	1/113	0.9432458477081953	1.0	0	0	0.35398230088495575	0.020682591950105064	AKT1S1
Lysosome	1/121	0.9537069008081818	1.0	0	0	0.3305785123966942	0.015669053420323407	CTSC
Class A GPCRs (rhodopsin-like)	3/253	0.9539457666461015	1.0	0	0	0.47430830039525684	0.02236290475689931	HTR7;ADRB1;GPR3
MAPK signaling pathway	4/314	0.9561860368014349	1.0	0	0	0.5095541401273885	0.02282944494166437	MAPK11;EGF;MAP3K9;FGFR4
Influenza viral RNA transcription and replication	1/125	0.9581917112507288	1.0	0	0	0.32	0.013666369569193149	RPL26L1
Innate immune system	4/319	0.9598241605176124	1.0	0	0	0.5015673981191222	0.020566860150322747	APP;MAPK11;IRAK1;CD55
PDGFB signaling pathway	1/129	0.9622428000578976	1.0	0	0	0.31007751937984496	0.011934409069483176	ACTN4
Lipid and lipoprotein metabolism	7/489	0.9630434750952558	1.0	0	0	0.5725971370143149	0.021562131621733215	PI4K2B;TBL1XR1;ELOVL2;FHL2;ELOVL7;TNFRSF21;CTGF
Parkinson's disease	1/131	0.9641189452154209	1.0	0	0	0.30534351145038163	0.011157436589384392	UQCRH
Membrane trafficking	1/133	0.9659020359820757	1.0	0	0	0.3007518796992481	0.01043394344030168	TPD52
Metapathway biotransformation	1/174	0.9880200528093195	1.0	0	0	0.22988505747126436	0.0027706402470183225	HS3ST1
Phospholipid metabolism	1/205	0.9945747442490583	1.0	0	0	0.19512195121951217	0.0010614684675817035	PI4K2B
Generic transcription pathway	3/377	0.9961319714742173	1.0	0	0	0.3183023872679045	0.0012335900355268184	TRIM28;TBL1XR1;CTGF
Olfactory transduction	2/432	0.999802399144242	1.0	0	0	0.18518518518518517	3.6596366922104964E-5	OR2W3;PDE1C
